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ABSTRACT
RNA helicases are vital components of various pathways for post-transcriptional
gene regulation. TgHoDI is a newly identified member of the DEAD-box RNA helicase
family in Toxoplasma gondii. This study was aimed at characterizing the function of
TgHoDI in post-transcriptional regulation during various stages of the parasite life cycle.
Through immunofluorescence analyses, TgHoDI was found to colocalize with mRNA
aggregates in cytoplasmic foci. Furthermore, colocalization studies of TgHoDI with
PABPC3 identified these proteins as components of RNA aggregates known as stress
granules. Cycloheximide and arsenite treatment of extracellular parasites revealed the
presence of mechanisms involved in the determination of mRNA fate in Toxoplasma.
Also, TgHoDI was found to functionally compliment the temperature sensitive phenotype
in Δdhh1 yeast, validating its role in stress response. These findings confirm that TgHoDI
is a vital component in the formation of stress granules and possibly involved in the
mechanisms of post-transcriptional gene regulation.
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CHAPTER I - LITERATURE REVIEW
1.1 Toxoplasma gondii as a model organism
Toxoplasma gondii is an intracellular parasitic protozoan and serves as a model
organism for the study of pathogenic Apicomplexa members including Plasmodium,
Neospora, Eimeria and Cryptosporidium [1]. In comparison to other Apicomplexa, T.
gondii is easily propagated in vitro using cell monolayers. Also, a high transfection
efficiency and the ability to stably express protein epitope tags allows for the study of
biochemical properties that are not readily expressed in other organisms. The haploid
nuclear genome which contains 14 chromosomes, consisting of approximately 8 x 107
base pairs [1], allows for the modification or elimination of genes through mutagenesis
without allelic complementation. Thorough documentation of mutagenesis and selectable
markers allow for the isolation of transformed parasites in gene replacement studies
through homologous and random recombination [2]. In addition, the well-established
mouse model and the ability to monitor host response has made T. gondii ideal for the
study of Apicomplexan biology.
1.2 Life cycle
Toxoplasma is unique in its capability of infecting and replicating in virtually any
nucleated avian or mammalian cell [3]. The parasite's life cycle consists of two parts;
sexual reproduction within the feline (definitive host) and asexual replication correlating
with non-feline infections (intermediate host) [4]. Due to its implication in human
disease, the asexual life cycle will be discussed in further detail. The asexual life cycle
consists of two distinct stages known as tachyzoite (tz) and bradyzoite (bz), which result
in acute or chronic infections, respectively [4]. In the acute tachyzoite stage, parasites are
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in a rapid growth form and are capable of active infection. Tachyzoites enter the host cell
by penetrating through the host cell membrane and become surrounded by a
parasitophorous vacuole (PV). Parasite replication within host cells occurs at a generation
time of 6 to 8 hours within the PV through the process of endodyogeny [3]. Endodyogeny
is a form of indefinite reproduction in which two progeny form within the parental
parasite [5]. The production of a large number of parasites, approximately 64-128, leads
to the rupture of host cells (lysis). Parasites then exit the cell, in a process referred to as
egress, and are then able to infect neighbouring cells [3]. Under the stress of the host's
immunity, tachyzoite to bradyzoite differentiation occurs, resulting in the formation of
tissue cysts approximately 7-10 days post-infection [4]. This marks the second asexual
stage, which is characterized by slow parasitic growth. Similarly to tachyzoites,
bradyzoite parasites divide by endodyogeny, resulting in increased cyst size [4]. These
cysts are found primarily in muscle tissue and the central nervous system, where they
remain for the entirety of the host's life [3].
1.3 Clonal Lineages of T. gondii
Toxoplasma consists of three clonal lineages, type I (RH and GT-1), II (ME49)
and III (CEP and VEG), which differ in virulence and epidemiological occurrence [6].
Although the strains are divided amongst these three clonal groups, at any given locus the
three groups only possess two separate alleles, which are ~98% identical at the nucleotide
level [7]. All three strains share the trait of oral infectivity thereby bypassing the need for
the sexual stage of the parasitic life cycle [8]. This bypassing of sexual reproduction, as
well as the need of a definitive host, limits genetic recombination and hinders the
formation of a wider range of genotypes [9]. Furthermore, infection in intermediate hosts
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is typically caused by a single strain and therefore recombinant genotypes are unlikely to
emerge [8].
Studies by Sibley and Boothroyd (1992) sought to determine the variation in
parasitic strains by means of polymerase chain reaction (PCR) and restriction fragment
length polymorphisms (RFLPs) [10]. In the study, 28 isolates from a diverse set of hosts
were analyzed using a subset of gene probes previously used as characteristic markers for
the genetic and physical mapping of the Toxoplasma genome. An example of such a
marker, surface antigen-1 (SAG1), is a single-copy gene encoding the major surface
antigen [10]. RFLP analysis revealed that all three strains showed an identical RFLP
pattern for the genes studied, indicating the genetic homogeneity among the strains [10].
Consistent with this, the differences among the strains, at the genome sequence level, was
determined to be less than 1% [10]. Similar studies conducted by Howe and Sibley
(1995), which performed PCR/RFLP studies on 6 independent loci, determined that the
percentage of nucleotide divergence between estimated strains was <5% [11].
Furthermore, studies by Cristina et al. (1995) resulted in comparative results when
performing RFLP and isoenzyme analysis on 14 parasite isolates [12]. This genetic
homogeneity has lead to the conclusion that these virulent strains, I, II and III, were
recently derived from a single clonal lineage [13].
The studies conducted provided preliminary analysis of Toxoplasma genome,
which has since been fully sequenced by the J. Craig Venter Institute. The completion of
the parasitic genome subsequently lead to the assembly of the bioinformatic database
referred to as ToxoDB [14]. This database is a culmination of studies conducted by
several researchers in the field to provide access to the genomic sequence of all known T.
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gondii strains [15]. Furthermore, the database contains annotation of the type II strain
with analyses of express sequence tags (ESTs), single nucleotide polymorphisms (SNPs)
analyses, open reading frames (ORFs) identification, proteomic and microarray studies
[15]. Due to the highly similar genomes of the three clonal strains, data exhibited for the
type II strain provides an accurate representation of information on the remaining two
strains.
Although there is no significant variation at the genomic level, studies in mice
have shown that infections by the various clonal lineages result in altered pathogenesis;
with type I strains being highly virulent in comparison to the relatively non virulent type
II and III strains [10]. This enhanced virulence of type I is in part due to the overactivation of the Th1 immune response, which is a cell-mediated immunity targeting
intracellular pathogens [8]. Furthermore, type I strains share a combination of alleles at
many loci, which is not seen in non-virulent strains, indicating acute virulence is a result
of genotype variations [8]. Analysis of T. gondii strains in human disease has found an
increased frequency of type I stains in AIDS patients, however the majority of infections
are caused by type II strains [16]. Furthermore, type I has been associated with recurrent
ocular toxoplasmosis in immunocompromised patients, suggesting that type I is more
pathogenic [17]. Taken together however, most studies in North America and Europe has
identified type II strains as the most prevalent cause of human toxoplasmosis in
congenital and AIDS patients while type III is largely confined to animals [18, 19].
1.4 Pathogenesis
T. gondii is the causative agent of toxoplasmosis which effects a third of the
human population [6]. Infection can generally occur by ingestion of contaminated meat,
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water or the exposure to oocysts present in infected feces. During an acute acquired
infection, individuals exhibit influenza-like symptoms with limited cases of prolonged
fever, lymphadenopathy or retinochoroiditis [1]. As a result, clinical manifestations are
commonly limited to immunodeficient individuals such as AIDS patients. Among these
individuals, intracerebral focal lesions may result in encephalitis, that if left untreated,
can be fatal. Congenital toxoplasmosis may also occur and is a result of an acute infection
of an expectant mother. The ability of tachyzoite parasites to be transmitted through the
placenta, as well as the lack of a fetal immune system, causes infection in the unborn
fetus [6]. The severity of congenital infection varies; however, spontaneous abortions and
neurological disorders, such as toxoplasmic encephalitis and ocular toxoplasmosis may
occur [6]. The current drug therapy for toxoplasmosis consists of a drug regimen centered
around pyrimethamine in addition to either sulfonamides or clindamycin [1]. The
combination of clindamycin and pyrimethamine is used in patients with who do not
tolerate sulfonamides [20]. These drugs effectively kill parasites in the tachyzoite stage,
however do not target the chronic bradyzoite stage [1]. This, combined with the toxic side
effects of these drugs, creates the need for a more effective and long-term clinical
treatment. Due to the prevalence of Toxoplasma infection in the human population, it is
necessary to understand the developmental mechanisms behind stress response, primarily
those involved in parasite differentiation and cyst formation. Analysis of gene expression
and regulation which accompanies such cellular processes may allow for the
understanding of the underlying mechanisms responsible and assist in the determination
of better clinical treatments.
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1.5 Gene Regulation
Throughout the parasitic life cycle, a fine balance of transcriptional and
translational control occurs to maintain proper levels of gene expression. Gene regulation
is fundamental for the coordinate synthesis, assembly and localization of macromolecular
structures of the cell, thereby ensuring proper functioning of biological mechanisms
necessary for survival [21]. Gene regulation can generally be divided into two levels: (i)
transcriptional and (ii) post-transcriptional regulation.
(i)Transcriptional regulation ensures that the levels of transcripts are maintained at the
necessary levels throughout various growth and developmental stages. For transcription
to occur, certain regions of chromosomes (genomic DNA) must first be made accessible
to allow for the binding of the transcription protein complex. The accessibility of DNA is
altered by a class of chromatin remodeling enzymes, for example those capable of
covalently modifying histones. The genome of Toxoplasma contains several histone
acetyltransferases which were determined to be necessary in the transcriptional regulation
of chromatin bound to histone 3 (H3) and histone 4 (H4) [1]. The acetylation of lysine
residues on the N-terminal histone tails results in the transcriptional activation and
repression by the addition or removal of acetyl groups, respectively [22]. Similarly, the
addition of methyl groups to lysine and arginine residues on H3 and H4 has been shown
to confer gene activation and silencing in Toxoplasma, with five protein
methyltransferases and a lysine-specific demethyltransferase homologue identified [1].
Furthermore, several putative proteins were identified in the genome of Toxoplasma
whose eukaryotic homologues act in histone modification by means of activation,
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through phosphorylation, ADP-ribosylation, and ubiquitylation, or repression, by means
of sumoylation [1, 23].
Studies by Soldati and Boothroyd (1995) demonstrated that genomic regions
flanking ORFs, referred to as cis-elements, were able to confer both characteristic
specificity and strength of expression of endogenous protein coding regions [24]. These
elements identified in the 5'-flanking region vary in size from a hundred to thousands of
nucleotides and have been exploited in the construction of expression vectors, resulting in
the high expression of target genomic sequences [24]. Examples of these 5' exploited
promoter regions are the tachyzoite-specific expression vectors derived from lactate
dehydrogenase 1 (LDH1) or surface antigen 1 (SAG1) and bradyzoite-specific vectors
constructed from bradyzoite antigen 1 (BAG1) or enolase 1 (ENO1). Although specific
cis-acting elements in the 5'-flanking regions of many genes have been identified, such as
the six tandemly repeated 27 base pair repeats directing transcription initiation of SAG1,
the exact location of regulatory elements of many genes remains unknown [1].
The coupling of these cis-elements with sequence-specific DNA binding proteins,
known as trans-regulating factors, have been shown to control gene regulation of target
sequences. This is carried out by the binding of these factors to specific sequences
resulting in the promotion or repression of transcription by the activation or inhibition of
RNA polymerase, respectively [22]. These factors are classified on the basis of their
DNA binding domains which may consist of: (i) a helix-turn-helix, (ii) two cysteine-two
histidine zinc finger, (iii) a multi-cysteine zinc finger or the (iv) basic DNA binding
domain [25]. Stimulation of transcription results from the assembly of the basal complex,
which consists of RNA polymerase II and transcription factors such as transcription
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factor IIB (TFIIB), at specific activation domains present in the promoter of a gene [25].
In comparison, inhibition of transcription by protein factors may function in several
mechanisms including: (i) the binding of an inhibitory factor which directly represses a
gene, (ii) binding of a factor which interferes with the binding of stimulatory factors or
(iii) the quenching of stimulatory factors by binding of inhibitory units [25]. In
Apicomplexa, the presence of trans-regulating factors, such as TFIID, and the emergence
of proteins containing nucleotide binding domains within the parasitic genome suggesting
to the presence of such transcriptional regulation mechanisms in these organisms [1].
Studies by Vaquero et al. (2005) confirmed the action of such trans-regulating factors in
P. falciparum in which a DNA binding protein, PfMyb1, was determined to be involved
in a regulatory network of proteins required for parasite growth [26].
(ii) Post-transcriptional regulation is required for the completion of mRNA synthesis
and occurs prior to export of transcripts from the nucleus. Three major processes which
comprise the post-transcriptional alterations of pre-mRNA within the nucleus are the (i)
acquisition of a 5' cap structure, (ii) splicing out of introns and (iii) addition of a poly(A)
tail. After the synthesis of approximately 30 nucleotides, the addition of the 5' cap
structure occurs in a series of steps [27]. First, the pre-mRNA 5'-triphosphate is
hydrolyzed to a diphosphate by an RNA triphosphatase. Then, guanylyltransferase
catalyzes the addition of a GMP molecule to the recently hydrolyzed nucleotide residing
on the 5' end of the pre-mRNA. In the final step of the reaction, a methyltransferase
methylates the N7 position of the GMP, completing the cap structure [27]. Interestingly,
both the RNA triphosphatase and the guanylyltransferase remain attached to the mRNA
and act to recruit the cap binding complex (CBC) [27]. The CBC is believed to function
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in the stabilization of mRNA by hindering the ability of 5'-3' exonucleases to access the
mRNA.
The next processing event in eukaryotes is the splicing of non-coding sequences
known as introns. Within the pre-mRNA several consensus cis-elements are present
which are necessary for the splicing reaction. These elements are the 5' and 3' exon-intron
junctions (indicated by |) which are marked by the consensus sequences of AG|GURAGU
and YAG|RNNN (R: purine, Y: pyrimidine), respectively [27]. Furthermore, a
branchpoint is present approximately 100 nucleotides upstream of the 3' exon-intron
junction which contains a highly conserved adenosine [27]. Splicing occurs in two
distinct steps and is catalyzed by the spliceosome which is comprised of five small
nuclear RNAs assembled with other proteins [27]. These components are essential in the
assembly, stabilization and activity of the spliceosome complex, resulting in the
production of a pre-mRNA molecule comprised of exons alone.
The final step in nuclear processing of mRNA is the addition of a 3'
polyadenylated tail consisting of approximately 200 adenine residues. Prior to the
addition of poly(A) tail, the pre-mRNA must be cleaved at a site present between a highly
conserved AAUAAA sequence and a uracil or GU-rich motif known as a downstream
sequence element (DSE) [27]. This cleavage is performed by two multisubunit protein
complexes in association with two essential factors, cleavage factors I and II, which
direct cleavage of the pre-mRNA. Poly(A) polymerase, the enzyme catalyzing the
addition of the poly(A) tail, is usually required within the cleavage reaction complex and
directs the poly(A) addition. Poly(A) binding protein II then binds to the emerging
poly(A) tail and also enhances the processivity of the poly(A) polymerase [27]. Once all
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three processes are complete, the now mature mRNA can be exported from the nucleus to
the cytoplasm where it is capable of either undergoing active translation or becoming
translationally repressed.
1.6 Emerging paradigm of Gene regulation, cytoplasmic regulation of mRNA
Once messenger RNA (mRNA) is exported from the nucleus into cytosolic
compartments, the regulation of gene expression is further maintained through the
processes of (i) translation, (ii) mRNA degradation (decay) and (iii) mRNA storage. The
fate of transcripts, whether they are actively translated, degraded or stored is controlled
and reflected by the composition of messenger ribonucleoprotein (mRNP) complexes
which interact with mRNAs [28]. The flux of mRNP remodeling directs cytoplasmic
mRNAs among complexes such as (i) the polysome, for the translation process, (ii)
processing bodies (PBs) and (iii) stress granules (SGs) for degradation and storage,
respectively [29]. The composition of mRNPs play a vital role in dictating the fate of
transcripts with major mRNP remodeling occurring throughout the mRNA cycle.
mRNAs may be actively shuttled between each of the three mRNPs, resulting in dynamic
alterations in mRNP composition. An illustration of this dynamic cycle is shown below
(Figure 1.1).
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Figure 1.1 Cytoplasmic regulation of mRNA fate
Cytoplasmic mRNAs are engaged in three possible cellular processes (i) active
translation, where polysome structures are formed, (ii) degradation via processing bodies
and (iii) storage in stress granules. The image was modified from [30].
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(i) Regulation of translation
During translation, the 40S and 60S ribosomal subunits are recruited onto mRNA
transcripts by a number of eukaryotic translation initiation factors (eIFs) [31]. The
recruitment of factors, referred to as the initiation phase, can be directed in either a 7methylguanylate (m7G) 5'-cap dependent or independent manner. During cap-dependent
initiation the m7G 5'-cap structure is recognized by the initiation factors eIF4F, eIF4E and
eIF3 which then recruit the 40S ribosomal subunit [31]. The dependency on the m7G 5'cap structure allows for fine-tuning of gene expression by enhancing or repressing the
assembly and activity of the cap-binding complex through the reversible phosphorylation
of translation factors. Conversely, during cap independent translation an RNA structure,
referred to as an internal ribosome entry segment (IRES), aids in the assembly of
translational machinery at a position close to the initiation codon [31]. In either form of
initiation, once the ribosomal subunits are recruited, a downstream scanning for the
translation initiation codon (AUG) occurs and translation of a nascent polypeptide is
performed. These repetitive rounds of translation initiation, elongation and termination
occur in the mRNPs referred to as polysomes [32].
(ii) Regulation of mRNA decay
Cytoplasmic mRNA turnover is a vital aspect of cellular physiology and is a key
factor in gene expression. In eukaryotes, the degradation of mRNA occurs by three
cellular mechanisms: (i) endonucleolytic cleavage, (ii) specialized quality control
pathways or (iii) deadenylation dependent 3' to 5' decay [33].
Endonucleolytic cleavage is the degradation of mRNA transcripts without the
prior need for transcript deadenylation. In yeast, mRNAs stalled in translation elongation
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were shown to be recognized and targeted for endonucleolytic cleavage involving
proteins similar to translation termination factors such as the eukaryotic release factor
3(eRF3) [34]. This type of mRNA cleavage is also responsible for RNA-mediated gene
silencing (RNAi), resulting in the formation of 21-23 nucleotide RNA species that are
used in the targeting of the RNAi-induced silencing complex [33]. To monitor mRNA
biogenesis, quality control mechanisms occur in eukaryotic cells which cause the rapid
degradation of aberrant mRNAs [33]. These aberrant mRNAs are identified as those
transcripts with defective structures within the 5'-cap, start/stop codons or poly(A) tail.
For transcripts exhibiting a premature stop codon, non-sense mediated decay (NMD)
occurs which is the process of mRNA degradation without the prior necessity of poly(A)
tail shortening [33]. This process is responsible for the reduction of truncated proteins.
Similarly, the decay of transcripts with an absence of a stop codon is performed via
nonstop decay, which directs target mRNA to the exosome [33].
Deadenylation dependent degradation of mRNA occurs via two pathways, both of
which begin by the shortening of the poly(A) tail by the action of deadenylases [33]. In
yeast, the first pathway results in the degradation of mRNA in a 3' to 5' direction
catalyzed by the exosome. The exosome is a large complex of exonucleases which
function in RNA degradative and processing events [33]. In the second pathway,
following the shortening of the poly(A) tail, the decapping of the m7G 5'-cap structure is
performed by a holoenzyme consisting of Dcp1p and Dcp2p enzymes. The decapped
transcripts are then digested by a 5' to 3' exonuclease [33]. Mutagenesis resulting in the
loss of either of the subunits, Dcp1p or Dcp2p, results in a complete loss of decapping in
vivo, identifying the necessity of the holoenzyme in this pathway [34]. Furthermore,
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Dcp2p was identified as the catalytic subunit required for decapping while Dcp1p acts to
stimulate the activity of Dcp2p by increasing substrate interaction [34]. The activity of
Dcp1p/Dcp2p results in the release of m7GDP, leaving a product consisting of a 5'monophosphate bound to mRNA [35]. This product is the preferred substrate for
exonucleases, resulting in degradation of transcript. The expression of decapping
enzymes and presence of aggregated decapping factors within sub-cellular structures in
many organisms suggests that this mechanism is conserved throughout eukaryotes.
Decapping of mRNA is controlled by three major factors; the length of the
poly(A) tail, the translation status of the transcript and the ability of mRNA to assemble a
decapping complex [34]. The commonality of all these factors is the influence of mRNAspecific binding proteins which regulate decapping by either stimulating or inhibiting the
action of enzymes. The action of PABP, specifically its ability to protect the poly(A) tail
from degradation, inhibits decapping and subsequent mRNA degradation. PABP is
believed to act in decapping inhibition by two discrete mechanisms. Firstly, its physical
interaction with eIF4G, a component of the cytoplasmic cap-binding complex, may
inhibit decapping by enhancing mRNA translation. Interestingly, this stabilization of the
cytoplasmic cap-binding complex alone has been shown to inhibit decapping as well
[36]. The second mechanism of inhibition stems from in vitro studies which suggested
that PABP can bind directly to the cap structure and actively inhibit decapping [37]. The
second factor influencing decapping of mRNAs is the assembly of various protein
complexes which act to enhance the interaction of the decapping enzyme [34]. For
example, complexes in yeast containing Lsm1-Lsm7 proteins, Pat1p and Dhh1p have
been shown to enhance the decapping action of the Dcp1p/Dcp2p holoenzyme by aiding
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in the proteins recruitment to target mRNA [38]. For decapping to occur, there must be a
transition of the mRNA from a translationally active complex to an mRNP complex that
lacks translation factors. The dissociation of the cap-binding complex marks the
transition from active translation to transcript decay. This is followed by the formation of
specific cytoplasmic foci, referred to as processing bodies (PBs), where decapping factors
and 5' to 3' exonucleases are recruited [34].
(iii) Regulation via RNA storage in sub-cellular structures
Processing bodies: PBs are constitutive cytoplasmic aggregates containing
translationally repressed mRNPs. These RNA granules consist of non-translating mRNAs
and interacting proteins involved in translational repression, mRNA decay and RNA
interference [30]. Transcripts appear to be transiently associated with PBs, and if not
degraded, are released from PBs and incorporated back into active translation [28].
Transcripts could be targeted for 5' to 3' decay or remain translationally inactive, is
dependent on variations in the composition of these PBs [28]. In humans for example, the
interaction of Puf family members with the 3' untranslated regions (UTRs) of transcripts
and the Pop2p subunit of the Ccr4/Pop2/Not complex (found within PBs), directs
transcripts for repression and decay [29]. Similarly, the association of Dhh1 with mRNAs
in yeast results in the shuttling of transcripts to PBs [39]. Although the complete
composition of PBs has yet to be identified, PBs have core protein components consisting
of (i) the decapping enzyme Dcp1p/Dcp2p, (ii) activators of decapping and (iii) a 5' to 3'
exonuclease [29]. These core proteins can be referred to as the 5' repression-decay
complex.
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Prior to PB formation, transcripts are released from the polysomes. The
subsequent remodeling of mRNP complexes produces an mRNP containing the 5'
repression-decay complex [28]. In accordance with this, ribosomal subunits have not
been identified in PBs. The treatment of cells with translation elongation inhibitors, such
as lactimidomycin, prevents PB assembly and traps mRNP complexes within the
polysome [40, 41]. In comparison, inclusion of 5' repression-decay complexes have been
shown to be necessary for PB formation. The recruitment of this complex can occur
either by an intrinsic mRNA affinity or through the action of mRNP specific factors [28].
Specific structural or sequence targets within the mRNA transcript may result in the
recruitment of decapping factors and subsequent targeting to PBs. Alternatively, 5'
repression-decay factors interact with mRNA-specific complexes involved in translation
initiation inhibition or mRNA decay, resulting in PB assembly [33]. The importance of
the 5' repression-decay complex has been exhibited by studies which show an enrichment
of 5' decay factors within PBs as well as an increase in PB formation occurring from over
expression of individual factors [28]. Also, depletion of factors which recruit the 5'
repression-decay complex cause an impairment in PB assembly [28]. In addition to PBs,
SGs have also been shown to play a vital role in mRNA regulation during cellular stress.
Stress granules: In contrast to PBs, SGs are transient cytoplasmic aggregates
which occur in response to the cellular exposure to an environmental stress. Stresses,
such as heat shock, result in a sudden arrest of translation which leads to polysome
disassembly [42]. The disassembly and subsequent rearrangement of mRNPs could
initiate the formation of SGs, which act as emergency storage locations for mRNAs. The
exposure of cells to translation initiation impairment drugs, such as hippuristanol, and the
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depletion of initiation factors can induce the formation of SGs [28, 42]. The core
components of SGs, which act as markers for all SGs, include components of the small
ribosomal subunit, translation initiation factors eIF3 and eIF4 and PABP [42]. The
composition of the protein complex confirms that these granules are aggregates of
mRNPs stalled in the translation initiation step [28]. Several other classes of proteins
have been identified in SGs, including mRNA-binding proteins linked to translational
silencing (i.e T-cell internal antigen-1; TIA-1) and RNA decay (i.e argonaute proteins;
AGO). However, these proteins are not present in all SGs [42]. According to Anderson
and Kedersha (2007), the assembly of SGs has been divided into three distinct stages
[42]. First, the stalling of translation initiation and the formation of the 48S mRNP is
caused by either drug-induced inactivation of eIFs or stress-induced eIF2α
phosphorylation. The formation of SGs is then enhanced by the interaction of SGnucleators with the 48S mRNP during a process termed primary aggregation [42]. The
transcripts then bind to other proteins which undergo protein-protein interactions amongst
themselves during secondary aggregation, thereby allowing for the subcellular SG
structures to become microscopically visible [42]. The fate of these repressed mRNAs is
determined by their association with specific RNA-binding proteins present within the
SGs. These transcripts could (i) remain stored, (ii) be reinitiated into translation or (iii)
selected for decay. Although the direct observation of mRNA shuttling between PBs and
SGs has yet to occur, several proteins such as Dhh1 are shown to be capable of shuttling
in and out of these granules [30]. Furthermore, PBs and SGs have been seen to contain
the same mRNA species [30]. Intriguingly, throughout this dynamic remodeling process,
RNA helicases continually emerge in several stages of translational repression. These
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proteins have also been shown to colocalize within both SGs and PBs and affect the
stability of these granules [30]. These helicases may alter the composition of mRNPs or
promote mRNP formation by their activity to remodel RNA-protein complexes, thereby
dictating the fate of transcripts [30]. The subsequent alterations result in granule stability
and finally the recruitment of specific factors to mRNPs [30]. These functions suggest the
important role of these RNA helicases in mRNA storage, repression and subsequently,
gene regulation.
1.7 Helicases
Helicases are nucleic-dependent NTPases capable of unwinding DNA or RNA
duplex substrates [43]. Their functions are defined by their ability to translocate
directionally along the nucleic acid phosphodiester backbone and to simultaneously
unwind double-stranded regions by utilizing energy gained from ATP hydrolysis [44].
Helicases play vital roles in various cellular processes, including replication, translation,
ribosome synthesis, RNA metabolism and nuclear export processes [45]. All helicases
contain central core domains identified by signature motifs which couple NTP binding,
NTP hydrolysis and the conformational changes in protein structure, resulting in DNA or
RNA remodeling [44]. These signature motifs include: (i) the conserved motifs, Walker
A and B, involved in the binding and hydrolysis of the NTP and (ii) an “arginine finger”
that plays a key role in energy coupling to unwinding activity [44].
Using their consensus sequences and signature motifs, helicases, which are
generally composed of multiple repeating units, are classified into different superfamilies,
families, and subclasses (Fig. 1.2). The first tier of classification is based on the features
of their central cores whether they contain (i) two RecA-like domains, (ii) six RecA-like
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domains arranged in a (hexameric) toroid or (iii) six AAA+ domains arranged in a
(hexameric) toroid [44]. To further categorize helicase members into different
subfamilies, two additional criteria were used. First, their enzymatic activities are towards
single and/or double stranded nucleic acids as their substrates [44]. The helicase members
that utilize single-stranded nucleic acids as their substrates are identified as α helicases,
whereas those using double stranded nucleic acids as their substrates are β helicases [44].
For example, the members of Superfamily 1 (SF1) are α helicases because they will
engage only single stranded nucleic acids, while the members of SF6 are β helicases [44].
Second criterion used for grouping helicase members is their translocation polarity. When
the helicase members translocate from 3’- to 5’-terminus, they are called type A
helicases. Those, that translocate from 5’- to 3’-terminus, are type B helicases [44]. With
these classification criteria, six helicase superfamilies are formed (Fig. 1.2).
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Figure 1.2 Classification of Helicase Superfamilies
Helicases can be classified into six major superfamilies: SF1 and SF2 are
composed of two repeating subunits of RecA-like domains while SF3-SF6 helicases are
composed of 6 repeating subunits of either RecA-like or AAA+ monomers.
Classifications are also based on translocation polarity (3'-5' as Type A or 5'-3' as Type
B) and whether the nucleic acid substrate is single (α) or double stranded (β).
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The core domain structure is used in the identification of each helicase
superfamily. Specifically, SF1 and SF2 helicases contain a core consisting of a tandem
repeat of two RecA-like domains while SF3-6 helicases contain a core consisting of six
individual RecA- or AAA+-like domains arranged in a toroid. The common features of
these core structures will be further discussed and are illustrated below (Fig 1.3).

Figure 1.3 Representative core structures of helicase superfamilies.
(Left) SF1 and SF2 helicases contain a tandem repeat of RecA-like domains (Nand C- core). An NTP analogue (black) is shown at the interface of the core domains. The
Walker A (1) and B (2) motifs are located on the N-core side of the cleft. Motif 6
contains the conserved arginine finger residue required for ATP coupling. (Right) SF3-6
helicases contain a core of six individual RecA- or AAA+-like domains in a toroid. This
configuration results in six nucleotide-binding pockets; shown to be occupied with NTP
analogues (black). H1 and H2 are equivalent to the Walker A and B motifs which are
located on the opposite side of the cleft compared to the conserved arginine finger. This
image was modified from [44].
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1.8 Main characteristics of helicase superfamilies (SFs) based on their core domains
Hexameric RecA-like domain: SF4 and SF5 helicases contain six units of RecAlike domains, which are homologous to the bacterial recombinase-A (RecA) protein,
arranged to form a barrel-like structure (Fig. 1.2, right panel) [44]. RecA was first
identified in E. coli to function in the repair and maintenance of nicked DNA [46].
Among SF3 and SF4 helicase members, each RecA-like monomer contains three
domains: (i) an amino domain which functions in RecA polymer formation, (ii) a central
domain involved in nucleotide and NTP binding, and (iii) the carboxy domain which
facilitates interfilament association [46]. The central domain contains two nucleotide
binding regions, one for single and another for double stranded nucleotides, as well as
one ATP binding region known as the phosphate binding loop (P-loop) [46]. The RecAlike hexameric structure is responsible for the forming of six nucleotide binding pockets,
one per domain interface. It is noted that all members of SF4 and SF5 superfamily have
the conserved hexameric core and type B translocation directionality [44]. Interestingly,
there is no functional commonality among members. For example, SF4 helicases, which
were first identified in bacteria and bacteriophages, share five conserved motifs (H1,
H1a, H2, H3 and H4) and act as replicative helicases [47]. SF5 helicases, whose best
example is Rho helicase, are functionally responsible for termination of transcription in
bacteria [23].
ATPases Associated with diverse cellular Activities (AAA+): The core domain of
SF3 and SF6 helicase members contain six subunits of AAA+ core domain organized in a
toroid (Fig. 1.3, right panel) [44]. Notably, the proteins that contain AAA+ domain are
also considered as members of P-loop NTPases [48]. In addition, the proteins containing
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AAA+ domain have the Walker A and B motifs which are responsible for nucleotide
binding and nucleotide hydrolysis [49]. These AAA+ domain containing proteins
characteristically carries a conversed catalytic glutamate which is not seen in other
NTPases [50]. The AAA+ domain is highly conserved and contains approximately 200250 amino acid residues [48]. Three critical motifs were described within the AAA+
conserved domain and are known as (i) sensor 1, (ii) sensor 2 and (iii) 'box' sequences
[51]. Sensor 1 contains a conserved polar residue, which is aspargine, threonine or
histidine, to function as a nucleotide sensor for binding and hydrolysis by interacting
directly with the γ-phosphate of ATP [50]. Sensor 2 contains a conserved arginine residue
and functions in the binding and hydrolysis of ATP as well as the communication and
movement between subunits [50, 51]. Finally, the "box" motifs are believed to function in
ATP hydrolysis as well as intersubunit communication. SF3 and SF6 members vary in
functions and non-central core structures [51]. SF3 helicases were originally identified in
DNA and RNA viruses, such as parvo- and papillomaviruses, and are associated with
activities such as origin recognition and unwinding [47]. These SF3 helicase members
share four conserved motifs (A, B, B' and C) and exhibit type A translocational
directionality [44]. On the other hand, the numbers of SF6 helicase members are limited.
To date, SF3 has only the archeal and eukaryotic mini chromosome maintenance (MCM)
protein complex and the RuvB proteins as the members of the superfamily [44, 52].
MCM is considered as the main eukaryotic replicative helicase and exhibits both A and B
type directionality while RuvB proteins work as a dsDNA translocases which processes
Holliday junctions [44].

23

RecA-like domain: SF1 and SF2 helicases contain two identical units of RecAlike domains which are connected by a flexible linker, forming a cleft which contains the
ATP-binding site (Fig. 1.2, left panel) [53]. The N- core domain contains the conserved
motifs I-III and the Q motif, while the C- core domain is composed of motifs IV-VI [54].
These motifs will be discussed in further detail in Section 1.10. Target nucleic acids
become associated opposite the ATP-binding site and forms interactions which spans
across both domains (Fig. 1.2, left panel) [44]. As shown by X-ray crystallography and
various biochemical studies, the binding and hydrolysis of ATP is facilitated by the
closure of the cleft between the two RecA-like domains, resulting in nucleic acid
unwinding [55].
The structural features of SF1 and SF2 helicase members have continuingly been
subjected to extensive analyses. For example, with intense structural analyses, the
formerly known seven conserved motifs of SF1 were resolved to contain more unique
motifs within, which gave rise to two SF1 subfamilies, names SF1A and SF1B. Notable,
SF1 members utilize single-stranded nucleic acids as their substrate, while SF2 members
could accept single or double stranded nucleic acids are their substrates. SF1 and SF2
exhibit A and B type directionality [44].
1.9 SF2 helicases
SF2 contains the largest number of characterized members which are complex by
nature. The major subfamilies are: (i) DEAD-box RNA helicases, (ii) the RecQ-like
family and (iii) the Snf2-like enzymes [44]. Uniquely, the members of SF2 subfamilies
are capable of using either RNA or DNA as their substrates [53]. More specifically,
DEAD-box helicases interact with RNA, while RecQ-like and Snf2-like helicases use
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DNA as their substrates. Aside from sharing core structural feature, SF2 helicases contain
auxiliary domains on their C- and N- termini to confer specificity or complementary
catalytic activities [56]. More specifically DEAD-box RNA helicase subfamily play vital
role in cellular activities including the disruption of mRNPs and the remodeling of RNA.
1.10 DEAD-box RNA Helicases
DEAD-box RNA helicases were first described by Gorbalenya et al.(1989), when
a group of NTPases were defined based on sequence similarity to the eukaryotic initiation
factor 4a (eIF4a) to contain several common sequence elements (Fig.1.4) [57]. Since
then, DEAD-box RNA helicases have been classified as the largest helicase family of
SF2. The mode of RNA binding in DEAD-box RNA helicases is highly conserved
throughout the family [58]. The two central core domains make a contact to its RNA
substrate in a non-sequence-specific manner spanning over any consecutive five
nucleotides [45]. The interaction involves exclusively the sugar backbone of the RNA.
Bound to the enzyme, RNA is bent in a conformation which differs from those seen in
most SF2 helicases [45]. In this single stranded RNA (ssRNA) conformation, the RNA
undergoes a sharp bend due to ionic and hydrogen bond interactions with several motifs
within domain 1 (Fig. 1.4) [59, 60]. The resulting ssRNA structure inhibits the formation
of a double stranded helix, giving rise to RNA unwinding [60]. This local strand
separation is unique to DEAD-box RNA helicases, as it abolishes the need for
translocation in order for strand separation to occur [45].
Additionally, most DEAD-box helicases contain auxiliary domains known as Nterminal and C-terminal extensions (NTE/CTE, Fig 1.4). These extensions vary in length
and composition from one protein to another and have been shown to interact with RNA
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or other proteins [55]. These interactions characterize specific DEAD-box RNA
helicases, thereby targeting them for specific physiological functions [58]. Furthermore,
these auxiliary domains have been shown to result in protein dimerization, regulate
functional properties of the RecA-like core domains as well as contribute additional
enzymatic activities [45].

Figure 1.4 Conserved motifs of the DEAD-box RNA helicase subfamily
DEAD-box RNA helicases are composed of 13 conserved motifs: motifs I-VI and
the Q motif. Motifs interacting with RNA are boxed in white while those involved with
ATP are in dark grey. Motif III which is involved in coupling ATP binding/hydrolysis
with helicase activity is in light grey. The Q motif is known to be specific to the family of
DEAD-box helicases while Motif II contains the conserved D-E-A-D amino acid
sequence. NTE and CTE are the auxiliary N- and C- terminal domains, respectively. The
domains were resolved from the yeast DEAD-box protein Mss116. This image was
modified from [45, 61].
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1.11 Structural features of DEAD-box RNA helicases
DEAD-box RNA helicases participate in diverse cellular functions in a wide
variety of organisms, ranging from S. cerevisiae to Homo sapiens. Their functions have
been implicated in almost all aspects of RNA metabolism including transcriptional
control, nuclear mRNA export, translational regulation and RNA decay [58]. To be
classified as a DEAD-box RNA helicase, the protein must harbor 13 conserved motifs
(Fig. 1.3). Herein the nature and function of each conserved motif, namely the Q motif,
motifs I, Ia, Ib, Ic, II, III, IV, IVa, V, Va, Vb and VI will be addressed [45].
The Q motif which was identified upstream of motif I and is comprised of a conserved
nine amino acid sequence [62]. The sequence of this motif is as follows: GaccPohlQ;
where "a" is an aromatic group, "c " is a charged group, "o" is an alcohol, "h" is a
hydrophobic group and "l" is an aliphatic group [45]. This motif is characterized
specifically by a conserved glutamine residue which is present in 99% of protein
sequences analyzed [62]. Although the invariant glutamine residue is present in many
helicases, several other conserved residues within the Q motif are only conserved among
DEAD-box proteins. As a result, the Q motif is suggested to be specific to DEAD-box
helicases [61]. This motif is necessary for efficient binding of ssRNA and conformational
changes occurring due to nucleotide binding and ATP hydrolysis. Therefore it has been
suggested that the Q motif acts as a sensor of the bound nucleotide and regulator of
subsequent ATPase activity [45]. Furthermore, the base pair of the adenine nucleotide
interacts specifically with the conserved glutamine residue, resulting in a strong
preference for ATP over other nucleotide triphosphates [45].
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Motif I (AxTGxGKT) is known as the Walker A motif is vital for both ATPase and
helicases activity. It was found to function in NTP binding by coordination of a Mg2+ ion
as well as by forming hydrogen bonds with pyrophosphates of target nucleotides [63].
Mutational studies targeting the alanine, lysine or final threonine residues abolished
ATPase activity and reduced the affinity for and rate of ATP hydrolysis [56].
Furthermore, this motif is crucial in regulating protein activity through interactions with
the phosphate of nucleotides, motif II, motif III and the Q motif [56].
Motif II (DEAD) is known as the Walker B motif and is necessary for ATPase activity
[63]. Along with the Walker A motif, these motifs are not only present in DEAD-box
helicases, but are common to all helicases as well as numerous NTPases. Mutational
studies reveal similar results as those seen with the Walker A motif, with abolished
ATPase and helicase activity without altered RNA binding [56]. Furthermore, the
presence of the amino acid sequence Asp-Glu-Ala-Asp in this motif inspired the name of
this family of helicases.
Motif III (SAT) has been suggested to play a role in coupling ATP binding and
hydrolysis with helicase activity [56]. This concept originated due to experimental
mutations resulting in interrupted substrate unwinding without affecting ATP binding and
hydrolysis. However, the role of this motif remains ambiguous due to mutations in motif
III varying the impairment of protein function between members present in the SF1 and
SF2 superfamilies [56].
Motif VI (HRIGRTGR) was determined to function in both ATPase and RNA binding
activity and is located at the interface of domains 1 and 2. Mutational analysis resulted in
the abolishment of helicase activity through the impairment of ATP binding and
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hydrolysis [56]. These studies targeted the conserved histidine, the second arginine as
well as the glutamine residues. Furthermore, it was determined that the second arginine
indeed interacted with the gamma-phosphate of the ATP, confirming the motif function
in the coupling of NTP hydrolysis with helicase activity [56].
Motif Ia (PTRELA) and Ib (TPGR) are present in domain 1 and do not participate
directly in ATP binding or hydrolysis however, are necessary for RNA binding in
association with motifs IV and V [56]. Although motifs I, II and II have been well
characterized, the roles of motifs Ia, Ib, IV and V remain ambiguous, as the motifs have
been less studied [45]. Studies by Schwer and Meszaros (2000) have shown that motif Ia
may also participate in structural rearrangements facilitated by ATP binding and
hydrolysis [64]. Motif IV is poorly studied, resulting an unclear consensus sequence for
the motif. This motif is found at the bottom of domain 2 and has been suggested to play a
role in the binding of ssRNA [56]. Finally, Motif V (TDxxARGID) is suggested to
function in RNA-binding in conjunction with motifs Ia, Ib and IV. Studies of this motif
have also implicated its role in signal transmission of RNA binding to the ATPase
domain and subsequent regulation and hydrolysis of ATP. It was also determined that
contacts do occur between motif Va and the ribose sugar, however the role of these
contacts is unknown [56].
1.12 Important homologues of DEAD-box RNA helicases
With intense studies, there are hundreds of members documented. Herein three
members of DEAD-box RNA helicases, whose structural and functional features are
highly related to the newly characterized DEAD-box RNA helicase member described in
this study, will be reviewed.
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Yeast DEAD/H helicase-1 (Dhh1) is one of over twenty DEAD-box proteins identified
in Saccharomyces cerevisiae. Dhh1 plays a vital role in mRNP remodeling during mRNA
metabolism and decay [39]. Mutagenesis analysis has shown that Dhh1 knock-out
mutants have (i) prolonged half-life of target mRNAs, (ii) accumulated deadenylated
transcripts and (iii) the lack of removal of the 5' m7G cap [39]. Furthermore, it has been
that Dhh1 has the physical association with Pop2p (deadenylase) and Dcp1a in
processing bodies [65]. Taken together, these studies strongly suggested the involvement
of Dhh1 in mRNA turnover and its specific role in mRNA decay.
It has also been shown that Dhh1 is not only involved in mRNA decay, but also
plays a role in the storage of mRNAs during environmental stress [66]. Under glucose
deprivation, cellular localization of Dhh1 was within stress granules, therefore indicating
a possible role in translational repression which does not involve mRNA degradation
[66]. Furthermore, yeast cells whose Dhh1 expression was abolished showed deficient in
stress granules formation [66]. Intriguingly, the presence of Dhh1 in both stress granules
as well as processing bodies indicates a possible role in the shuttling of mRNAs between
the two cellular compartments.
Conserved germline helicase-1 (CGH-1) is a DEAD-box helicase found in
Caenorhabditis elegans and has been found to function in translational repression as well
mRNA degradation [67]. Biochemical analyses have shown that CGH-1 functions by
associating with maternal mRNAs to protect them from degradation. These studies have
shown that CGH-1 does not only play a vital role in translational repression of maternal
mRNAs by means of storage in germline specific granules (P-granules) during oocyte
development but also protects target mRNAs by enhancing mRNA stability [67].

30

Although the function of CGH-1 has been identified, the mode by which that function is
performed remains elusive. A model describing the involvement of CGH-1 in maternal
mRNA storage and repression has been hypothesized by Parker and Rajyaguru (2008)
and may have implications pertaining to this studies.
In this model, CGH-1 is involved in translational repression by forming mRNPs
which accumulate in P-bodies. These cellular foci may result in the degradation of target
mRNAs by the recruitment of decapping enzymes [67]. This concept is centralized
around the ability of CGH-1 homologues, such as Dhh1, to interact with decapping
enzymes and other components of P-bodies [66]. Furthermore, CGH-1 would transition
mRNAs from P-bodies to stress granules where they may interact with proteins involved
in translational activation. The evidence for this is the fact that CGH-1 has been purified
in RNA-protein complexes including poly(A) binding protein and other proteins which
are known components of stress granules [67].
Development of zygote inhibited (DOZI) is a DEAD-box member found in Plasmodium
berghei and shown to function in translational repression in the female gametocyte [68].
Two specific mRNAs, p25 and p28, which encode proteins necessary for zygote
development, were found to be translationally repressed within cytoplasmic foci until
after gamete formation and fertilization [68]. Intriguingly, immunofluorescence studies
identified

the

colocalization

of

DOZI

within

the

same

mRNP

structures.

Immunoprecipitation studies and subsequent analyses identified the interaction of
substantial amounts of both transcripts, as well as many other transcripts, with transgenic
DOZI protein [68].
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Mutagenesis showed that DOZI null mutants exhibited a total loss of development
of zygotes into mature ookinetes while maintaining normal production of gametocytes
and gametes [68]. Furthermore, Northern analysis and oligonucleotide microarray studies
showed the loss of p25 and p28 transcripts as well as the reduction of another 370
transcripts; many of which were involved in ookinete motility and invasion and
previously shown to be translationally repressed [68]. Interestingly, 92 transcripts were
shown to increase in abundance which may indicate further functions of DOZI in mRNA
regulation [68]. Overall, the study identified DOZI as a central player in the repression
and regulation of gametocytespecific transcripts. Furthermore, the loss of protein
expression severely hindered the ability of the parasite to regulate mRNAs in the female
gametocyte.
When the composition of the cytoplasmic foci was further analyzed, sixteen major
protein factors were present within these structures, including: (i) PABP, (ii) CARI/Trailer Hitch Homolog (CITH), (iii) eIF4E, (iv) enolase and (v) Acetylation Lowers
Binding Affinity proteins 1 and 2 (Alba 1 and Alba 2) [69]. These studies suggest that
DOZI could act primarily in mRNA storage rather than degradation and is a translational
repressor necessary for proper zygote development [69]. Furthermore, the study also
suggests that such mRNPs are evolutionarily conserved in protozoans. The regulation of
gene expression could be controlled by the formation of mRNPs to ensure the stability
and storage of mRNAs.
1.13 DEAD-box RNA helicases in Toxoplasma gondii
During the complex life cycle of T. gondii there is a necessity for mechanisms to
be in place which regulate gene expression during the parasitic exposure to various
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environmental stresses throughout the continuous rounds of host invasion and egress. The
discovery of DEAD-box RNA helicases as vital components in post-transcriptional
regulatory pathways in several organisms has thereby lead to the current study of
homologous RNA helicases in Toxoplasma gondii. Bioinformatic analyses have
identified 81 putative proteins with functional implications in gene regulation; 20 of
which contain conserved amino acid sequence motifs relating to the DEAD-box RNA
helicase family. Another 26 proteins were identified as putative ATP-dependent RNA
helicases due to the presence of both ATP and nucleotide binding regions. A summary of
the DEAD-box and ATP-dependent RNA helicase genes can be found in Appendix A.
A member of the DEAD-Box RNA helicase family in Toxoplasma exhibits a high
sequence homology to several highly characterized DEAD-box RNA helicases. These
homologues, which were previously discussed above, play vital roles in the posttranscriptional gene regulation of target transcripts in their respective organisms. The
amino acid sequence alignment of the proteins is shown in Figure 1.5. The RNA helicase
exhibited a sequence similarity of 68% to Dhh1, 67% to CGH-1 and 81% to DOZI. Due
to the high sequence homology to DOZI, this RNA helicase will be referred to as
TgHoDI (Toxoplasma gondii Homologue of DOZI; gene ID Tggt1_089230).
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Figure 1.5 Sequence alignment of DEAD-box members with the putative TgHoDI
The amino acid sequences of Dhh1, CGH-1, DOZI and TgHoDI were aligned
using the Clustal Omega tool [70]. An asterisk (*) indicates a fully conserved residue, (:)
indicates strongly similar properties while (.) signifies a weakly conserved residue.
Conserved motifs are highlighted in grey with motif II (D-E-A-D) in green.
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The possibility of TgHoDI to be involved in post-transcriptional gene regulation
was further suggested in a study by Braun et al. (2010), which attempted to decipher the
role of Toxoplasma homologue of Argonaute (TgAgo) in RNA silencing. This study
identified TgHoDI (referred to by its gene ID 583.m00676) as one of four DEAD-box
RNA helicases that immunoprecipitate with the Argonaut silencing complex [71]. Also,
studies by Al Riyahi et al. (2006) found that stable knockdown TgAgo clones exhibited
an impaired ability to silence target gene expression in comparison to wild type parasites;
thereby identifying the involvement of Ago as a vital component in the double-stranded
RNA-induced gene silencing in T. gondii [72]. The apparent association of TgHoDI with
TgAgo, as shown by Braun et al. (2010), may therefore implicate the involvement of
TgHoDI in post-transcriptional gene regulation in T. gondii.
1.14 Research Hypothesis and Objectives
TgHoDI is hypothesized to be a major player in post-transcriptional gene
regulation as a central component of mRNPs in Toxoplasma due to its high sequence
similarity to several vital DEAD-box RNA helicases as well as its involvement within an
mRNA silencing complex. This study is the first to analyze a specific DEAD-box
homologue in Toxoplasma. Specifically, the research is aimed at the determination of the
involvement of TgHoDI in post-transcriptional gene regulation and possible involvement
in the translational repression of mRNA.
The specific aims are as follows:
(i) To examine the genetics and expression profiles of TgHoDI through the use of
bioinformatic analysis.
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(ii) Determination of protein function through the analysis of transgenic parasite clones.
These clones will be used in studies including:
a) Immunodetection of cellular extracts to determine expression of TgHoDI during
tachyzoite and bradyzoite stages.
b) Immunofluorescence analysis for identification of protein localization.
c) Fluorescent in-situ hybridization for localization with mRNA transcripts.
d) Colocalization analysis with proteins involved in translational repression.
e) Determination of alterations in TgHoDI localization as a result of drug treatments.
(iii) Complementation studies involving temperature sensitive yeast strains.
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CHAPTER II - RESULTS
2.1 Toxoplasma gondii Homologue of DOZI (TgHoDI)
DEAD-box RNA helicases have been described as vital components in posttranscriptional gene regulation in several organisms. In Toxoplasma, a DEAD-box
member, which has the highest sequence homology to the proteins CGH-1, Dhh1 and
DOZI, hereby referred to as TgHoDI, was chosen as the subject of this study. This study
is aimed at determining the presence of mechanisms to regulate gene expression and the
cytosolic mRNA fate in T. gondii. First, bioinformatic analyses were performed using
Toxodb.org to uncover essential information pertaining to TgHoDI. The information
obtained was subsequently used in the design and construction of recombinant TgHoDI
reporter plasmids.
The genomic sequence in the TgHoDI locus spans either 4028bp (type I) or 4037
bp (type II and III), of all 3 parasite strains on chromosome XI. Within the TgHoDI locus
5 exons and 4 introns were found, with the 5 exons encoded by a 2073 nucleotide
sequence which also contains UTRs of 339 and 306 nucleotides at the 5' and 3' ends,
respectively. The locus of TgHoDI is annotated as Tggt1_089230 for type I,
TgME49_313010 for type II and TgVeg_097040 for type II parasites [15]. The
illustration of the genomic sequence and splicing of TgHoDI for type I Toxoplasma,
which will be used in this study, is shown in Figure 2.1. The genomic sequence which
spans from 2,642,433 to 2,646,460 on Chr. XI results in a coding sequence (CDS) of
1428 base pairs and encodes a 475 amino acid protein with a calculated molecular weight
of 53.462 kDa and an isoelectric point of 8.58. An alignment of the nucleotide and
corresponding codon sequence for TgHoDI is shown in Figure 2.2. Furthermore, the
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derived amino acid sequence is 475 amino acids in length and similar in all strains with
only one amino acid variation observed at the 70th residue (Fig. 2.3, highlighted in red).
In type I this residue is an asparagine while in type II and III it is a serine.

Figure 2.1 Genomic organization of TgHoDI
The 1.42 Kb coding sequence of TgHoDI is the result of the splicing of 5 exons
from the genomic sequence which spans from 2,642,433 to 2,646,460 (4.0 Kb) on
chromosome XI. Open boxes represent exons in the genomic sequence while introns are
shown as connector lines. The genomic location of exon flanks is illustrated by values
above the exon-intron junction; i.e exon 1 spans from 2,645,840 to 2,646,460.
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ATGAGCGCAGCCTACTACACCCGCAGACCCGGGCTCTCTGGATCGCCCTATCCCCAGTCTCAAAACGGAAGCGGCGAGAGAAAC
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
M S A A Y Y T R R P G L S G S P Y P Q S Q N G S G E R N
GCGAACCAGGGGCAAGGCCCGGCGCCCTACGGCTACCCGCCTCAGCAGCGCATGCAACACTTCAGTCAGCCTCAAAACAGTGTG
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
A N Q G Q G P A P Y G Y P P Q Q R M Q H F S Q P Q N S V
CCTTCCCAGCCGGCCAACCCCGCGCACGTCGACCCGAACAACAATCCTGAGGGCGACGAAGGCTGGAAAAGCAAAGTCGTCCTG
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
P S Q P A N P A H V D P N N N P E G D E G W K S K V V L
CCTCCAAAGGACAACCGCGTGAAAACCGAGGATGTGACGAAGACGAAAGGCACGGACTTTGAGGAGTATTTTCTACGACGTGAA
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
P P K D N R V K T E D V T K T K G T D F E E Y F L R R E
TTGTTGATGGGCATCTTCGAGAAAGGCTTCGAAAAGCCGTCGCCAATCCAAGAAGCGTCGATTCCAATTGCTCTCGCCGGGAAA
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
L L M G I F E K G F E K P S P I Q E A S I P I A L A G K
AACATCCTCGCTCGGGCGAAAAACGGCACTGGAAAAACCGCCGCGTTCTCGATTCCTCTCCTCGAAAAGTGTCAGACGTCGAAG
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
N I L A R A K N G T G K T A A F S I P L L E K C Q T S K
CGTTACATCCAAGGGCTGATTCTGGTTCCGACCCGTGAGCTGGCGCTGCAGACGAGCGCAGTGGTGAAGGCGATTGGGAAGCAT
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
R Y I Q G L I L V P T R E L A L Q T S A V V K A I G K H
ATGAACGTTCAGTGCATGGTGTCGACGGGAGGCACGAGCCTGCGTGACGATATTATGCGGCTGTACAACCCGGTGCATGTACTC
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
M N V Q C M V S T G G T S L R D D I M R L Y N P V H V L
TGTGGGACGCCGGGAAGAATTCTGGACCTGGCGAACAAGGGTGTCGCAGACTTGAGCAACTGCCATATGGTGGTCATGGACGAA
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
C G T P G R I L D L A N K G V A D L S N C H M V V M D E
GCAGACAAACTGCTCTCGGCGGAGTTTCAACCGATTGTCGAGGAACTCATCAAGTTCGTCCCGCGTGAGAGGCAAATTCTGATG
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
A D K L L S A E F Q P I V E E L I K F V P R E R Q I L M
TACTCCGCGACCTTCCCGGTCACGGTCAAAGACTTCAAACACAAGTACCTGCCAGATGCTCACGAAATCAACCTCATGGACGAA
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Y S A T F P V T V K D F K H K Y L P D A H E I N L M D E
CTCACGCTCAAGGGTGTCACGCAGTACTACGCCTTCGTCGAAGAACGCCAAAAAGTTCACTGCCTTAACACTCTATTCTCGAAG
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
L T L K G V T Q Y Y A F V E E R Q K V H C L N T L F S K
CTTCAAATCAACCAAGCAATCATTTTCTGCAACAGCGTGACTCGTGTGGAGCTTCTGGCGAAGAAGATCACGGAACTCGGATAC
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
L Q I N Q A I I F C N S V T R V E L L A K K I T E L G Y
TCGTGCTTCTACATCCATGCGCGGATGATGCAGTCCCACAGAAACCGGGTTTTCCACGATTTCCGGAACGGGGCGTGTCGCTGC
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
S C F Y I H A R M M Q S H R N R V F H D F R N G A C R C
CTCGTGTCGTCCGACCTCTTCACACGTGGAATCGACATTCAGTCCGTTAATGTCGTTATCAACTTCGACTTCCCAAAGAACTCT
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
L V S S D L F T R G I D I Q S V N V V I N F D F P K N S
GAGACATATCTGCACCGCATTGGGCGCTCCGGTCGCTTCGGACACCTCGGACTTGCCATCAACCTTATCACTTACGACGACCGT
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
E T Y L H R I G R S G R F G H L G L A I N L I T Y D D R
TTCAACCTCTACCGAATTGAGAGCGAACTTGGTACCGAAATTCAGCCGATTCCGAGCCAGATTGACGAAGCAATTTAC|ACATAG
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::|:::--F N L Y R I E S E L G T E I Q P I P S Q I D E A I Y | T

Figure 2.2 Nucleotide and Codon sequence of T. gondii DEAD-Box protein TgHoDI
Translation of nucleotide coding sequence to the corresponding amino acid
sequence for TgHoDI. Analyses was performed using Nucleotide Amino Acid Alignment
(NAP) software. (|) Indicates interruption of ORF prior to last threonine for the addition
of sequence tags for functional analysis in the study.
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Type_II
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*******************************************************

Figure 2.3 Amino acid alignment for TgHoDI protein in three T. gondii lineages
The amino acid sequences of TgHoDI for the three clonal strains of T. gondii
were aligned using the Clustal Omega tool [70]. An asterisk (*) indicates a fully
conserved residue, while (.) signifies a weakly conserved residue. Variation in amino acid
sequences is highlighted in red while putative phosphorylation sites are in grey [14, 15].
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Gene expression profiles revealed mRNA levels of TgHoDI equal in all three
clonal strains. However, further analysis of mRNA expression levels of TgHoDI for the
different asexual stages was conducted only in the type II (Me49) clonal strain [15]. Due
to the high sequence similarity between the three strains, which has been previously
addressed, the data obtained may be taken as a representation of expression in the type I
(RH) strain used in this study. The transcript levels remain relatively unaltered during
intracellular/extracellular conditions as well as during bradyzoite differentiation.
Furthermore, variation in mRNA expression was only identified in unsporulated oocysts,
which exhibited a decrease in mRNA levels.
Microarray data of all examined samples identified the presence of 110 SNPs, of
which 106 were synonymous and four non-synonymous, all within the CDS [15].
Furthermore, SNP analysis of the three clonal lineages identified the presence of 35 SNPs
(five in the CDS, two in 5' UTR), only one of which is non-synonymous. Interestingly, no
identified SNPs were found for analysis of type II and III parasite lineages. This data
correlates with the high amino acid sequence similarity observed throughout clonal
strains. Three possible phosphorylation sites were identified through mass-spectrometry
at serine residues at the 15th, 20th and 24th amino acid position within type I (RH) strain
(Fig. 2.3). These residues are conserved among the three strains and suggest posttranslational modifications implicated in protein function. A summary of the variations of
TgHoDI in the three strains are presented in Table 2.1.
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Clonal Strain
ToxoDB Gene ID
Chromosomal
location

Genomic Sequence
Length

Type I (RH)

Type II (Me49)

Type III (Veg)

Tggt1_089230

TgME49_313010

TgVEG_097040

2,642,433 to
2,646,460
(Chromosome: XI)

3,032,131 to
3,036,167
(Chromosome: XI)

3,020,945 to
3,024,981
(Chromosome: XI)

4028 bp

4037 bp

4037 bp

Coding Sequence
Length

1428 base pairs

Amino Acid
Composition

475 amino acids

Molecular Weight

53462 Da

53435 Da

Isoelectric Point

53435 Da

8.58

Table 2.1 Summary of Bioinformatic data on TgHoDI in three clonal strains
Data obtained from ToxoDB database comparing several characteristics of the
DEAD-box RNA helicase TgHoDI in Toxoplasma [15]. The three clonal strains show
high sequence similarity at the transcriptional and translational level with almost identical
coding sequence lengths, amino acid composition and isoelectric points.
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2.2 Generation of Transgenic Toxoplasma strains expressing recombinant tagged
TgHoDI at physiological levels
To establish a system allowing for the functional study of TgHoDI, we adopted to
C-terminally tag with (a) a streptavidin-FLAG tag (SF; 21 a.a., 8.42 kDa) and (b) yellow
fluorescent protein (YFP; 239 a.a, 29.56 kDa). Moreover, to access the level of
expression at normal physiological levels, the tag sequence was introduced into the
chromosomal locus by homologous recombination (knock-in) in the ΔKu80 parasite
strain. This strain was instrumental for the generation of knock-in mutants because the
Ku80 protein, which functions in non-homologous end-joining pathways, was removed
and therefore the ΔKu80 strain allows for only homologous recombination [73]. The
nucleotide sequence encoding the protein tags were inserted prior to the last codon
(ACA-threonine) in the open reading frame (Fig. 2.2, indicated by |). Due to the fact that
commercial antibodies against DEAD-box proteins in T. gondii are unavailable, the
presence of an epitope tag would allow for the immunological studies necessary to
decipher the possible role of TgHoDI.
To isolate and identify parasite clones stably expressing SF and yellow
fluorescent protein (YFP) PCR analyses for the presence of designed sequences within
the genomic DNA was performed using four specific oligonucleotide primer sets
(Appendix B). Two sets of oligonucleotides either (a+b' and b+b') or (a+c and b+c)
allowed for the confirmation of recombinant genomic sequences for TgHoDI-SF and
TgHoDI-YFP, respectively (Fig. 2.4). The oligonucleotides (b') and (c) specifically
amplified the sequences present within the 5' region of the recombinant protein tags and
provided a means of identification of clones by the amplification of recombinant bands at
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~3 kb and ~4 kb, corresponding to the introduced nucleotide sequence, which were not
present in the parental strain (Fig. 2.4). The use of two oligonucleotides (a) and (b)
upstream within the coding region of TgHoDI allowed for the confirmation of integration
of recombinant sequences into the genome, rather than transient expression of the
recombinant plasmid. The combination of these oligonucleotides with the oligonucleotide
(a'), which targets the 3' region of TgHoDI, were used as internal controls and resulted in
bands at ~3 kb and ~3.5 kb for both parental and transgenic strains.

Figure 2.4 PCR analysis of transgenic T. gondii strains expressing recombinant
TgHoDI
ΔKu80 parasites were genetically modified to contain transgenic sequences
allowing for the analysis of endogenous TgHoDI protein. (Top) Illustration of transgenic
and parental genomic sequences with PCR primer binding regions for the three parasite
clones. (Bottom) PCR analysis for the confirmation of recombinant sequence integration
into the T. gondii genome. Amplification of bands of ~3 and 4 kb in transgenic clones,
and not in the parental ΔKu80 strain, confirmed successful tagging of TgHoDI protein.
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To monitor the expression of recombinant protein, positive clones and parental
strains were analyzed using appropriate antisera (Fig. 2.5). When parasite lysates were
analyzed with α-GFP and α-FLAG antisera, bands were observed at ~83.0 kDa and ~61.9
kDa corresponding to the expected sizes for TgHoDI-YFP and TgHoDI-SF protein,
respectively (Fig. 2.5). Lactate dehydrogenase-1, ~35 kDa, was used as a loading control
in the analyses. This data confirms the expression of recombinant protein and supports
the results obtained from PCR analyses.

Figure 2.5 Western blot analysis for confirmation of transgenic TgHoDI protein
Immunoblot of stable transgenic strains expressing TgHoDI-SF and TgHoDI-YFP
protein. The presence of bands at ~61.9 and 80.0 kDa in transgenic strains, and not the
parental ΔKu80, confirm successful expression of recombinant TgHoDI-SF and TgHoDIYFP, respectively. Antisera against lactate dehydrogenase-1, ~35 kDa, was used as a
loading control for analyses.
2.3 Gross analysis for newly generated parasite strains in comparison to the
parental ΔKu80 strain
2.3.1 Doubling time
To determine the effects of recombinant tagged protein on the growth of T. gondii
parasites, transgenic clones were analyzed in comparison to the parental ΔKu80 strain.
Equivalent number of parasites were allowed to infect HFF monolayers and growth was
analyzed for various periods. The number of parasites in a total of 100 vacuoles were
counted per study, with analyses performed in triplicate for each of the three clones. After
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24 hours it was observed that transgenic and parental clones exhibited similar replication
patterns with almost half of the total number of vacuoles containing eight parasites (Fig.
2.6). Approximately 50.3% of ΔKu80 parental vacuoles, 45.7% of SF-tagged and 45.0%
of YFP-tagged clones contained 8 parasites. This gives an average doubling time of
approximately 8 hours for all monitored clones, which is similar to previously reported
values [1]. Similarly, after 36 hours almost half of the total vacuoles analyzed contained
16 parasites, reinforcing the approximation of an 8 hour doubling time. At 36 hours,
approximately 50.7% of ΔKu80 parental vacuoles, 46.3% of SF-tagged and 46.7% of
YFP-tagged clones contained 16 parasites. The similarity in parasite growth when
comparing transgenic and parental strains demonstrates that the addition of protein tags
had minimal effect on the ability of transgenic parasites to duplicate.
2.3.2 General protein expression
To determine if the addition of protein tags altered parasite phenotypes, the
expression of LDH1 was used to monitor variations in parasite metabolic processes for
tachyzoite transgenic strains (Fig. 2.7). The level of expression was analyzed as a
percentage of α-tubulin (Tub) expression. α-Tubulin is a structural component of the
parasite and therefore was used as a baseline for comparison. For the parental ΔKu80
strain, the relative expression of LDH1 was found to be ~93.6% with SF and YFP strains
exhibiting relative expression values of ~91.1 and 81.6%, respectively. These variations
of 2% and 12%, for SF and YFP respectively, indicate minimal variation in metabolic
processes for the transgenic strains. Furthermore, these values indicate that the size of the
tag does not greatly influence the cellular phenotype of the parasites.
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Figure 2.6 Growth analysis of transgenic and parental clones at 24 and 36 hours.
Parental (ΔKu80) and transgenic strains were allowed to infect HFF monolayers
and the number of parasites were counted per vacuole 24 and 36 hr post-infection. At 24
hours, vacuoles for both parental and transgenic clones were found to contain 8 parasites.
At 36 hours post-infection, the majority of vacuoles contained 16 parasites. Analyses
were performed in triplicate with standard deviation shown (error bars).
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2.3.3 Ability to differentiate
The addition of tags could alter the ability of parasites to undergo tachyzoite to
bradyzoite differentiation. We thus used a three day CO2 starvation and alkaline
treatment protocol to induce differentiation of newly generated clones in comparison to
the parental. Three days post-infection, parasite cultures were harvested and Western blot
analyses performed. Antisera against BAG1 were used to determine parasites
differentiation to the bradyzoite stage. Once again, expression of BAG1 was compared to
the level of Tub expression. Parental ΔKu80 parasites were found to have a relative
expression of ~26.4% while transgenic SF and YFP clones exhibited levels of ~59.7%
and 64.1% (Fig. 2.7). This translates into a 2.26 and 2.46 times increase in BAG1
expression for SF and YFP strains in comparison to the parental strain, indicating an
overall increase in bradyzoite differentiation for transgenic clonal parasites.
To compare the TgHoDI levels between the two asexual stages of Toxoplasma,
the relative expression of recombinant protein was analyzed as a percentage of α-tubulin
in tachyzoite and bradyzoite stages. In tachyzoite parasites, SF and YFP transgenic clones
exhibited relative expression levels of 83.9% and 83.4%, respectively. In comparison,
bradyzoite parasites were found to express relative TgHoDI levels of 58.3% and 60.7%
for SF and YFP transgenic clones, respectively (Fig 2.7). For tachyzoite parasites there is
a calculated 1.43 and 1.37 time increase in TgHoDI expression for the SF and YFP
clones when compared to their counterparts in the bradyzoite stage. Due to the lack of
commercial antisera against endogenous TgHoDI, expression levels could not be
compared to the wild type ΔKu80 strain.
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Figure 2.7 Comparative protein expression for determination of possible phenotypic
variations between transgenic and parental Toxoplasma strains
Parasite lysates were subjected to Western blot analysis and subsequent
densitometric analysis to determine the affects of adding a protein tag on parasite cellular
processes. Protein densities were compared as relative levels with the structural protein αtubulin as the baseline for analyses. LDH1 levels are not effected in transgenic clones
while bradyzoite differentiation appears to be amplified in these parasite strains. Studies
were performed in triplicate with error bars representing standard deviation obtained.
Statistical analysis was performed via two-tailed student t-test with p<0.05 with (*)
indicating significant variation among analyzed samples.
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2.4 Attempt to control the level of TgHoDI via ligand induced degradation
To determine the function of TgHoDI in Toxoplasma, it was necessary to develop
a system to alter the level of TgHoDI protein. Phenotypic variations could then be
monitored as a function of changes in protein level and function. To establish a system
for functional studies, TgHoDI was fused to a ligand-controlled destabilizing domain
(ddFKBP, 20.75 kDa). This system provides rapid, reversible and fine-tuned regulation
of protein levels due to selective stabilization of the tagged protein by the reversible
binding of a synthetic ligand, referred to as Shield-1. In the absence of ligand, the
ddFKBP causes degradation of tagged protein because of an inherited instability
conferred by the fusion protein from the ddFKBP. The addition of a synthetic ligand
stabilizes the ddFKBP and shields it from degradation [74]. The coding sequence of
ddFKBP was induced between streptavidin and FLAG to allow the read through
translation to give TgHoDI-strep-ddFKBP-FLAG (Fig. 2.8). As with previous
recombinant proteins constructed in this study, the tag sequence was introduced into the
locus within the parental ΔKu80 parasite strain, resulting in a C-terminally tagged fusion
protein (Fig. 2.8).
To identify parasite clones stably expressing tagged protein, positive clonal
parasites were analyzed using appropriate antisera (Fig. 2.8). Analysis of parasite lysates
with α-FLAG antisera revealed a single band at 74.20 kDa corresponding to the expected
sizes for TgHoDI-DDSF (Fig. 2.8). Tub, 50.11 kDa, was used as a loading control in the
analyses with TgHoDI-SF (61.9 kDa) as a positive control. This data confirms the
expression of recombinant protein in transgenic clonal Toxoplasma strains.
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To determine if the fusion of ddFKBP to TgHoDI allowed for fine-tuned
manipulation of protein expression, the confirmed transgenic clones were first analyzed
in the presence and absence of Shield-1 ligand (1 µM). For this preliminary experiment,
transgenic parasites, which were sub-cultured previously in media containing Shield-1,
were grown in the absence of ligand for 2 passages (~4 days) and parasite lysates were
subjected to Western blot analysis. The Antisera against α-FLAG revealed bands
corresponding to TgHoDI-DDSF in both treated and untreated samples (Fig. 2.9). This
demonstrated the inability of the ddFKBP to destabilize and cause subsequent
degradation, of the recombinant protein. TgHoDI-SF was once again used as a positive
control. As conducted previously, the relative density of recombinant proteins was
compared as a percentage of α-Tubulin expression. It was observed that the absence of
Shield-1 had little effect on the expression TgHoDI-DDSF protein, as demonstrated by
relative densities of 66.5% and 63.1% for treated and untreated parasites, respectively.
Furthermore, these values are comparable to those obtained for the TgHoDI-SF clones
(59.9%) in the study. The results obtained demonstrate an inability of the C- terminally
fused ddFKBP to destabilize TgHoDI protein. However, this inability to alter protein
levels, which may be attributed to the C- terminal placement of the destabilizing domain
on TgHoDI, may hint to protein function in cellular processes. Unfortunately, the results
obtained indicate that the destabilizing domain system cannot be used for subsequent
phenotypic analysis for variations of protein expression.
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Figure 2.8 Confirmation of transgenic TgHoDI-DDSF protein
ΔKu80 parasites were modified to express a TgHoDI-DDSF fusion protein for the
manipulation of protein expression. (Top) Illustration of transgenic coding sequence of
TgHoDI-DDSF with ddFKBP flanked by streptavidin and FLAG tags on the N- and Cterminus, respectively. (Bottom) Immunoblot of stable transgenic strains expressing
TgHoDI-DDSF protein. Antisera against FLAG identified the presence of a single band
at 74.2 kDa in two transgenic clones (1 and 2) confirm successful expression of
recombinant protein. TgHoDI-SF, 61.9 kDa, was used as a positive control. Antisera
against α-tubulin, 50 kDa, was used as a loading control for analyses.
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Figure 2.9 Analysis of transgenic TgHoDI expression in the absence of Shield-1
Transgenic parasite lysates were subjected to Western blot and subsequent
densitometric analysis to determine the ability of Shield-1 ligand to stabilize recombinant
protein. (Top) Western blot of TgHoDI-DDSF stable clones in the presence and absence
of Shield-1 at increasing protein concentrations (right to left). TgHoDI-SF was used as a
positive control for the analyses. (Bottom) Densitometric analyses of recombinant protein
levels as a function of α-tubulin expression. The absence of Shield-1 does not cause the
destabilization of TgHoDI, thereby exhibiting an inability to control protein expression.

53

2.5 Cellular localization of transgenic TgHoDI-SF
To decipher the role of TgHoDI in Toxoplasma, immunofluorescence assays
(IFA) were performed to determine the cellular localization of TgHoDI protein utilizing
transgenic clones expressing TgHoDI-SF. The localization of TgHoDI will assist in
analysis of protein function by revealing cytoplasmic or nuclear association in the
parasites. Dhh1 and DOZI, TgHoDI homologues, which function in translational
repression, were found to localize within cytoplasmic mRNP granules. It is necessary to
determine if TgHoDI exhibits comparable cellular localization, which may imply
similarities in cellular function. Intracellular transgenic tachyzoite parasites expressing
TgHoDI-SF protein displayed perinuclear labeling with a granular pattern dispersed
throughout the cytoplasm (Fig. 2.10). Extracellular parasites showed a distinct pattern
with highly localized foci of TgHoDI-SF protein (Fig. 2.10). Numerous foci are observed
throughout the parasite cytoplasm, however it appears that distinct aggregates are present
at the apical end of the parasites. These observations vary significantly from those for
intracellular tachyzoites where TgHoDI appears dispersed throughout the cytoplasm.
Furthermore, distinct aggregates appear to be localized surrounding the nucleus, which is
not observed in intracellular parasites. Interestingly, these results coincide with
previously described observations of cytoplasmic granules induced in extracellular
parasites as a response to environmental stress [75]. Bradyzoite parasites displayed a
granular cytoplasmic localization, similar to intracellular tachyzoite parasites, however
distinct foci were also observed at the basal end of the parasites (Fig. 2.10). Furthermore,
cytoplasmic foci appear to be larger than their counterparts in intracellular tachyzoite
parasites.
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Figure 2.10 TgHoDI localizes to the cytoplasm in intra- and extracellular
Toxoplasma
Immunofluorescence assay of transgenic T. gondii clone expressing TgHoDI-SF.
Parasites were immunostained with anti-FLAG and Rhodamine anti-mouse for detection
of TgHoDI-SF (red) and nuclear staining was performed with Hoechst (blue). (Upper
panel) Intracellular transgenic tachyzoite parasites display perinuclear labeling with a
granular pattern dispersed throughout the cytoplasm. (Middle panel) Extracellular
parasites showed a distinct pattern with highly localized foci of TgHoDI surrounding the
nucleus. (Lower panel) Intracellular bradyzoite parasites display a granular cytoplasmic
localization with large aggregates at the basal end of parasites. Images were acquired
using a 100x oil objective. Scale bars represent 5 µm.
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2.6 Fluorescent YFP-tag as an alternative to IFA for the localization of TgHoDI
The utilization of a fluorescently labeled protein would remove the necessity to
perform IFA targeting TgHoDI protein. This in turn would simplify analyses by
minimizing manipulation of samples and removing the need of multiple fluorescent
antigens for ensuing colocalization studies. However, the fusion of a yellow fluorescent
protein tag contributes an additional 21 kDa to the recombinant protein, therefore it is
necessary to ensure that cellular localization is not altered. In comparison to TgHoDI-SF
transgenic clones, TgHoDI-YFP intracellular tachyzoite parasites exhibit the same
perinuclear granular cytoplasmic localization (Fig. 2.11). TgHoDI-YFP appears widely
dispersed throughout the cytoplasm while being excluded from the nucleus. Furthermore,
the highly localized protein aggregates were observed for the extracellular parasites, with
distinct foci present at the apical ends and surrounding the nucleus (Fig. 2.11). These
results are similar to those obtained for the TgHoDI-SF transgenic clonal parasites. The
cellular localization of TgHoDI-YFP for the intracellular bradyzoite parasites, appears to
be a combination of both intra- and extracellular phenotypes. Although there are several
distinct aggregates of protein at the basal end, TgHoDI also appears to be dispersed
throughout the cytoplasm in smaller granular aggregates (Fig. 2.11). These observations
imply that in comparison to the SF transgenic clones, the additional size attributed by the
increased molecular weight YFP-tag does not alter the cellular localization of TgHoDI,
therefore enabling the use of this transgenic clone in further functional studies.

56

Figure 2.11 Addition of YFP does not alter TgHoDI localization
Fluorescent microscopy of transgenic T. gondii clone expressing TgHoDI-YFP
(yellow). After fixation, parasite nuclei were stained with Hoechst (blue)and imaged.
(Upper panel) Intracellular transgenic tachyzoite display the same perinuclear granular
localization of TgHoDI protein, as seen previously with TgHoDI-SF. (Middle panel)
Extracellular parasites display highly localized foci of TgHoDI surrounding the nucleus
and at the apical parasitic end. (Lower panel) Intracellular bradyzoite parasites exhibit
granular cytoplasmic TgHoDI localization with large aggregates at the basal end of
parasites. Images were acquired using a 100x oil objective. Scale bars represent 5 µm.
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2.7 TgHoDI colocalizes with mRNA granules in extracellular Toxoplasma
To determine the possible involvement of TgHoDI in the formation of subcellular
structures important to cytosolic mRNA fate, it was necessary to identify the location of
TgHoDI in correlation to mRNA and subcellular structures. In S. cerevisiae Dhh1 has
been shown to colocalize with cytoplasmic mRNA granules after induced environmental
stress such as glucose deprivation [66]. As previously described by Lirussi et al. (2011),
mRNA granules have been found to localize in punctate aggregates within the cytoplasm
of extracellular parasites [75]. These aggregates are proposed to play a role in stress
response and the translational repression of target transcripts [75].
Fluorescent in-situ hybridization (FISH) was performed on extracellular TgHoDIYFP transgenic parasites using an oligo-dT-biotin probe which was subsequently
conjugated to streptavidin-Rhodamine. In the extracellular parasites, mRNA appears to
be dispersed throughout the parasite with a granular pattern observed (Fig. 2.12). Several
distinct foci of mRNA aggregates appear within the cytoplasm surrounding the nucleus.
These results are in agreement with the previous study by Lirussi et al. (2011) which
identified distinct mRNA foci within the cytoplasm. TgHoDI-YFP localizes to distinct
cytoplasmic aggregates excluded from the nucleus (Fig. 2.12). TgHoDI appears to
colocalize with the mRNA granules at several distinct foci within the cytoplasm (as
indicated by arrows) (Fig. 2.12). The colocalization of TgHoDI with these mRNA
granules indicate the possible involvement in cytoplasmic regulation of mRNA. It is
necessary to further verify whether TgHoDI is involved in regulation by means of
translational repression or mRNA turnover.
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Figure 2.12 TgHoDI colocalizes with mRNA granules in extracellular Toxoplasma
Fluorescent in-situ hybridization was performed extracellular parasite transgenic
clone expressing TgHoDI-YFP (false coloured green). mRNA was targeted using oligodT-biotin which was subsequently conjugated to streptavidin-Rho (red). TgHoDI
localizes to distinct subcellular foci while mRNA displays a granular localization
throughout the cytoplasm. TgHoDI appears to colocalize with mRNA foci at the apical
parasitic end as well as other aggregates in the cytoplasm (as indicated by arrows).
Images were acquired using a 100x oil objective. Scale bars represent 5 µm.
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2.8 TgHoDI colocalizes with the Stress Granule Marker PABPC3
The observation that in extracellular parasites TgHoDI colocalizes with mRNA
granules led us to identify whether these structures are involved in mRNA degradation or
translational repression. IFA analysis was employed to identify if TgHoDI colocalizes
with poly(A) binding protein cytoplasmic-3 (PABPC3). Under normal cellular
conditions, PABPs isoforms (i.e PABPC1, PABPC3) bind to the poly(A) tails of mRNA
and regulates protein translation and mRNA stability [42]. Under environmental stresses,
such as oxidative stress or heat shock, translational arrest is triggered, initiating the
disassembly of polysomes [28]. Many proteins involved in normal processing events,
such as PABPs, would assume emergency functions and become associated to subcellular
aggregates known as stress granules [42]. As a result, proteins such as PABPC3 can be
employed as markers to identify SGs under induced stresses [42]. Lirussi et al. (2011)
showed an increase in cytoplasmic mRNA granules as a result of chemically induced
stress [75]. These granules were also shown to contain aggregates of PABP. Therefore, it
can be inferred that the mRNA aggregates observed (Fig. 2.11) are stress granules caused
by the stalling of translational machinery, rather than sites for mRNA turnover.
When IFA was performed on extracellular parasites using antisera against
PABPC3 in the transgenic TgHoDI-YFP strain, PABPC3 appears to be localized
throughout the parasite. Several distinct foci appear dispersed throughout the cytoplasm
with a large aggregate present at the basal parasitic end (Fig. 2.13). The localization of
PABPC3 mimics that of total cellular mRNA previously observed (Fig. 2.13). Once
again, TgHoDI-YFP appears to localize specifically within aggregates in the cytoplasm.
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As observed for mRNA colocalization, there were several areas of colocalization between
TgHoDI and PABPC3 (as indicated by arrows) (Fig. 2.13).
To verify the results obtained from fluorescent microscopy, which identifies the
colocalization of TgHoDI with PABPC3 within these mRNA granules, confocal
microscopy was employed. Confocal microscopy allows for a higher resolution as well as
the ability to control the depth of field for acquired images. As expected, the
colocalization of TgHoDI with PABPC3 is observed at distinct foci within the cytoplasm
(Fig. 2.13). This further confirms the colocalization of TgHoDI with PABPC3
implicating TgHoDI as a component in stress granules. Therefore, it can be inferred that
TgHoDI may function in the translational repression of transcripts in extracellular
parasites during stress response.
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Figure 2.13 TgHoDI colocalizes with PABPC3 in extracellular Toxoplasma
Immunofluorescence analysis was performed on the extracellular parasite
transgenic clone expressing TgHoDI-YFP (false coloured green). (Upper panel)
Fluorescent imaging of antisera against PABPC3 (red) exhibits a granular localization
throughout the cytoplasm with distinct foci at the basal parasitic end. TgHoDI appears to
colocalize with PABPC3 at the apical parasitic end as well as other aggregates in the
cytoplasm (as indicated by arrows). (Lower panel) Confocal imaging of extracellular
parasites verify the colocalization observed with traditional fluorescent microscopy.
Fluorescent microscopy images were acquired using a 100x oil objective, with confocal
images obtained with 63x oil objective. Scale bars represent 5 µm.
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2.9 TgHoDI aggregates in extracellular Toxoplasma under Oxidative Stress
To determine if TgHoDI participates in stress response and is a member of RNPs
formed under stress conditions, two chemicals, cycloheximide and arsenite were utilized
for extracellular parasites. Cycloheximide treatment has been shown to prevent stress
granule assembly and promote the disassembly of pre-formed stress granules [76].
Cycloheximide inhibits translational elongation and traps mRNPs into the polysome
structure, thereby preventing the translocation of mRNA into stress granules [77, 78].
Lirussi et al. (2011) showed that arsenite treatment of extracellular parasites resulted in
increased mRNA granule formation [75]. Arsenite induces oxidative stress which results
in inhibition of translation and subsequent increase in granule formation [78].
To determine whether the granule structures in Toxoplasma can be influenced by
cycloheximide treatment, extracellular TgHoDI-YFP parasites were treated with
cycloheximide (50 µg/mL) for one hour. Parasites were subsequently analyzed using
FISH targeting total cellular mRNA or IFA employing antibodies against PABPC3. After
cycloheximide treatment, TgHoDI no longer appears to form cytoplasmic foci and is now
dispersed throughout the cytoplasm (Fig. 2.14, center panels). For both mRNA and
PABPC3, cycloheximide treatment appears to have a minimal effect, with the dispersed
granular localization observed again. As previously observed for the control parasites,
TgHoDI localized to distinct foci in the cytoplasm (Fig. 2.14, left panels). Both PABPC3
and mRNA appear dispersed throughout the parasite with several granular aggregates
observed. An overlay of TgHoDI with either PABPC3 or mRNA exhibit identical results
as previously observed with several distinct areas of colocalization.
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To determine the effect of arsenite to induce granule formation, extracellular
Toxoplasma parasites were treated with sodium arsenite (10 µM) for one hour. Once
again, parasites were analyzed using FISH targeting total cellular mRNA and IFA
employing antibodies against PABPC3. In comparison to the control, extracellular
parasites treated with arsenite exhibited an increase in the size and number of TgHoDI
aggregates within the cytoplasm (Fig. 2.14, right panels). An increase in the abundance
of mRNA granules is observed dispersed throughout the parasite. This observation is in
agreement with a previously described study by Lirussi et al. (2011) identifying the
effects of drug treatments on mRNA granule formation in Toxoplasma [75]. Interestingly,
PABPC3 does not exhibit the same drastic increase in aggregate size and number as seen
for both TgHoDI and mRNA (Fig. 2.14). Overlay images of TgHoDI with either
PABPC3 or mRNA exhibit similar areas of colocalization as previously observed,
indicating involvement of TgHoDI in these mRNPs (Fig. 2.14). These observations
demonstrate that TgHoDI is a component of stress induced granules in Toxoplasma and
therefore may be a vital component in post-transcriptional gene regulation.
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Figure 2.14 Treatment of extracellular parasites with chemical agents alters
TgHoDI localization
IFA and FISH were performed on the extracellular parasite transgenic clone
expressing TgHoDI-YFP (false coloured green). (Upper) Fluorescent imaging of antisera
against PABPC3 and oligo-dT (red) for control parasites. TgHoDI-YFP extracellular
parasites were treated with cycloheximide (50 mg/mL) (middle panels) or sodium marsenite (10 µM) (lower panels). Addition of drug treatments appear to alter cellular
localization of TgHoDI. Images were acquired using a 100x oil objective. Scale bars
represent 5 µm.
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2.10 TgHoDI functionally complements Δdhh1 in S. cerevisiae
To evaluate whether TgHoDI could possess a comparable function as Dhh1, we
sought to determine whether TgHoDI could complement the temperature sensitive (TS-)
phenotype exhibited by Δdhh1 S. cerevisiae strains. In yeast, Dhh1 functions in mRNP
remodeling during mRNA decay by interaction with target transcripts leading to
activation of decapping [68]. Furthermore, under glucose deprivation Δdhh1 cells
exhibited a reduction in stress granule formation, indicating its possible role in
translational repression during environmental stress [67]. Knock-out studies by Chang et
al. (2003) identified Dhh1 as a non-essential protein in yeast viability, however Δdhh1
strains exhibited impaired growth at both 30oC and 37oC [65]. The sequence similarity
between Dhh1 and TgHoDI (69% identity) lead to the analysis of complementation
experiments which may shed light on the physiological function of TgHoDI in
Toxoplasma.
The Δdhh1strain showed a TS- phenotype at both 30o and 37oC in comparison to
wild-type (wt) which coincides with previously described observations (Fig. 2.15) [65].
The growth defect is seen to a greater extent for analyses conducted for 24 hours in
comparison to the 48 hour time point (Fig. 2.15). ΔDhh1 cells transformed with empty
plasmid (negative control) showed identical growth to the non-treated Δdhh1 strain
confirming the inability of parental vector to alter cell growth (Fig. 2.15). For the
expression of Dhh1, cells were transformed with a low copy centromeric plasmid
expressing Dhh1 from its endogenous promoter. At 24 hours, transformed cells were able
to completely rescue the TS- phenotype. Cells exhibited growth similar to the wt yeast
strains at both 30o and 37oC and the rescued phenotype was further exemplified after 48
hours in which transformed cells exhibited large colonies (Fig. 2.15).
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To express TgHoDI in yeast, cells were transformed with a high copy number
plasmid (2µm) expressing TgHoDI under the strong yeast GPD promoter. After 24 hours,
transformed Δdhh1cells exhibited a partially rescued TS- phenotype at both 30o and 37oC
in comparison to wt and Dhh1 complemented strains (Fig. 2.15). At 48 hours the ability
of TgHoDI to compliment the TS- was better observed as indicated by larger yeast
colonies. Although the phenotypic rescue was observed at both temperatures, the ability
of TgHoDI to complement yeast growth was observed to a greater extent at 30oC. In
comparison to cells transformed with Dhh1, phenotypic complementation with TgHoDI
appears to occur to a lesser extent, with fewer, smaller colonies observed. Taken together,
these results suggest that TgHoDI may act as a functional homologue to Dhh1 in stress
response. However, the deviation in TgHoDI's ability to complement growth to wild type
levels, in comparison to Dhh1, leaves open the possibility that TgHoDI functions in a
similar but non-identical manner to Dhh1 in yeast.
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Figure 2.15 Expression of TgHoDI complements TS- phenotype of Δdhh1 yeast
strain
Δdhh1 yeast strains were transformed with either an empty vector, Dhh1 or
TgHoDI for complementation of TS- growth defect. (Upper panel)At 24 hours, Dhh1 was
able to restore growth to wt levels at both 30o and 37oC. At both temperatures, TgHoDI
partially complements the growth defect of Δdhh1 as demonstrated by smaller colony
sizes in comparison to wt.(Lower panel) After 48 hours, Dhh1 is observed to fully
complement the phenotypic growth defect at both temperatures.
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CHAPTER III- DISCUSSION
TgHoDI belongs to the highly conserved DEAD-box RNA helicases which
includes the C. elegans CGH-1, S. cerevisiae Dhh1 and P. berghei DOZI [65, 67, 68].
Over the past several decades, members of this protein family have been implicated in a
diverse collection of cellular functions ranging from nuclear mRNA export to posttranscriptional gene regulation [55]. Knock-out studies have linked these proteins to a
decrease in organism viability with major changes in cellular pathways involved in stress
response and mRNP formation [65, 68]. The presence of these proteins in mRNPs in such
an array of organisms indicates the involvement of these proteins as evolutionarily
conserved components of mRNPs which function in the stability and storage of mRNAs.
The current study is aimed to determine the possible involvement of TgHoDI in posttranscriptional gene regulation in T. gondii.
Bioinformatic analysis of TgHoDI indicated the importance of its expression to
parasite viability. The 1428 bp coding sequence of TgHoDI encodes a 475 amino acids
with a molecular weight of 53.46 kDa. Nine highly characterized motifs of the DEADbox RNA helicase family were identified in TgHoDI, validating its classification within
this subfamily (Fig. 3.1). The amino acid sequence is conserved among the three clonal
lineages with only one residue difference observed (Fig 3.1). The asparagine residue in
type I is changed to a serine for both type II and III strains. Whether this variation may be
implicated in a altered protein structure or function was not deduced in the current study.
However, the presence of a single amino acid difference suggests a necessary
conservation in protein structure and function. Minimal variations in TgHoDI mRNA
levels during intracellular/extracellular conditions as well as during bradyzoite
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differentiation indicate its expression is required throughout the various stages of the
parasite life cycle. The increase in mRNA levels during oocyst sporulation may suggest
an additional role in oocyst development. TgHoDI mRNA levels were found to increase
four days into sporulation and remain elevated for the remainder of the parasitic life
cycle. Therefore, the expression of TgHoDI during early sporulation may be necessary
for the regulation of transcripts throughout the remainder of this developmental stage.
The DEAD-box RNA helicase DOZI in Plasmodium was found to be vital for the
translational repression and regulation of developmental mRNAs throughout the early
stages of zygote development [68]. This may suggest that TgHoDI functions similarly in
mRNA regulation during oocyst development as DOZI in zygote maturation.
Three conserved serine phosphorylation sites are present in the N-terminal
extension, indicating the possibility of post-transcriptional modifications (Fig. 3.1). The
presence of these sites in the N-terminal extension, which is known to play a role in
DEAD-box RNA helicase specificity and cellular function, may indicate the involvement
of post-translational modification in protein function. Similar phosphorylation sites have
been identified for other DEAD-box helicases, such as Dhh1, however the role of these
sites in post-translational modification and protein function have yet to be determined
[79]. Furthermore, in eukaryotes, including Toxoplasma and Plasmodium, the
phosphorylation of eIF2α is a conserved mechanism of stress response which represses
global protein synthesis and enhances formation of cytoplasmic mRNA granules [80].
This opens the possibility that similar phosphorylation mechanisms may be acting on
TgHoDI during cellular responses thereby altering cellular function.
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Figure 3.1 Summary of bioinformatic data pertaining to TgHoDI amino acid
sequence
The amino acid sequence of TgHoDI contains the highly characterized DEADbox motifs (highlighted in grey). Conserved sequences for these motifs is shown (Top).
The three phosphorylation sites believed to be involved in functional modifications are
identified on serine residues 15, 20 and 25. The single amino acid variation among the
three clonal lineages is present at residue 70 (highlighted in green). Introduction of
epitope tags was performed prior to the last threonine residue (shown by *).
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The transgenic TgHoDI-SG and TgHoDI-YFP strains exhibited similar doubling
time in comparison to the parental strain, which showed an approximate replication time
of approximately 8 hours for the two transgenic clones, indicating that the introduction of
epitope tag sequences did not hinder parasite replication. However, some variation in
tachyzoite metabolism was identified when protein levels of LDH-1 were analyzed. Also,
the levels of BAG1, a bradyzoite stage-specific marker, was induced in both SF and YFP
transgenic clones (Fig 2.7). The change of BAG1 expression, which was found to be
statistically significant, suggests that the addition of a C-terminal tag may interfere with
the downstream activity of TgHoDI during bradyzoite conditions (Fig. 3.1, indicated by
*). Linder et al. (2011) identified the importance of N- and C- terminal extensions of
DEAD-box RNA helicases for mRNA-protein and protein-protein interactions [55]. The
addition of protein tags of ~8.4 and ~29.6 kDa, for SF and YFP respectively, may
interfere with the ability of TgHoDI to interact with its partner(s). Such interactions
become vital when the parasite was exposed to stress conditions, i.e. bradyzoite growth,
whereas such conditions were not found in the tachyzoite growth condition. Thus, no
detrimental effect of the protein tags was observed under the tachyzoite conditions.
In the attempt to determine the possible function of TgHoDI, knockdown studies
utilizing the destabilizing domain system was employed. However, the addition of the
destabilizing domain (ddFKBP) failed to induce TgHoDI degradation (Fig. 2.9). This
inability to induce degradation indicates that the C- terminal region of TgHoDI may be
involved in protein-protein interactions, thereby shielding the ddFKBP from degradation
machinery. For future work, an alternative method that allows for the successful down
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regulation of TgHoDI expression would give a better understanding of protein function
and this mode of gene regulation.
Both transgenic strains, TgHoDI-SF and TgHoDI-YFP, showed similar cellular
localization, which indicates that epitope tag size has minimal effect on protein
localization. Also, Huynh and Carruthers (2009) showed that this knock-in of SF or YFP
tags at the native locus of a gene does not alter the location of the gene products [73]. The
absence of TgHoDI in the nucleus in all life stages may suggest its primary function in
the cytoplasm. The punctate cytoplasmic localization observed in both extracellular
tachyzoite and intracellular bradyzoite parasites mimics those previously described for
both Dhh1 and DOZI [65, 68]. Furthermore, mRNA granules have been recently
observed in extracellular parasites are associated with increased parasite viability [75]. In
comparison to bradyzoite parasites, the presence of very distinct cellular foci of TgHoDI
in extracellular Toxoplasma may indicate a variable stress response mechanism during
bradyzoite differentiation. In the bradyzoite stage, the localization of TgHoDI appears to
be between extra- and intracellular tachyzoite localization. Therefore, this may suggest
that under bradyzoite conditions the localization of TgHoDI was altered due to stress
response and that the location of TgHoDI reflects the dynamic of tachyzoite to bradyzoite
differentiation.
Mair et al. (2006) described the interaction of DOZI with 92 transcripts, thereby
validating its role in translational repression in Plasmodium [68]. In extracellular
tachyzoites, several distinct areas of colocalization were observed for TgHoDI with
mRNAs which indicates the interaction between the two (Fig. 2.12). This study is the
first to show that TgHoDI is an important component in post-transcriptional gene
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regulation. In agreement with this, the study by Braun et al. (2010) identified TgHoDI
(referred to as 583.m00676) as a member of the TgAgo complex which was subsequently
implicated in RNA-induced gene silencing [71, 72]. However, the incomplete
colocalization of TgHoDI aggregates with mRNAs, which is prominent at the basal
parasitic end, suggests that there is a second protein function which has yet to be
identified.
Colocalization of TgHoDI and mRNA granules suggests a possible function of
TgHoDI in post-transcriptional regulation. Therefore it is necessary to determine
TgHoDI's involvement in mRNA fate. DEAD-box RNA helicases are involved in the
storage and degradation of transcripts through the interactions with distinct proteins such
as PABPs and decapping enzymes (Dcp1/Dcp2) [39]. TgHoDI's colocalization with
PABPC3 at several areas throughout the cytoplasm suggests the involvement of TgHoDI
in stress response. The incomplete colocalization of TgHoDI with either stress induced
mRNA aggregates or PABPC3 may indicate another function within the cytoplasm (Fig.
2.12). This gives rise to the possibility that TgHoDI functions similarly to Dhh1 in both
the repression and degradation of transcripts.
To validate the participation of TgHoDI in the function of stress-induced RNA
granules, cycloheximide and arsenite treatment was performed. Extracellular parasites
subjected to cycloheximide treatment displayed a complete loss of TgHoDI aggregates in
the cytoplasm (Fig. 2.14). These observations are in agreement with previous studies
identifying the loss of the human Rck/p54 DEAD-box aggregates after cycloheximide
treatment [77]. Interestingly, the localization of TgHoDI post-cycloheximide treatment is
very similar to that observed for intracellular tachyzoite parasites (Fig. 2.11). This
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observation, in combination with the maintained expression of TgHoDI, can be seen as
an indication of multiple cellular functions. The ability of the same DEAD-box protein to
be involved in various cellular functions has been observed for Dhh1 [58]. Dhh1 was
initially determined to be involved in the decapping complex assembly, however recent
studies have shown that it is also implicated in stress response and granules formation
under glucose deprivation [39, 65]. Arsenite treatment of extracellular parasites increased
the size and prevalence of TgHoDI aggregates within the cytoplasm (Fig. 2.14). Also, an
increase in mRNA aggregate size and number is in agreement with previous studies
analyzing stress response in extracellular parasites [75]. This increase is directly
correlated to the oxidative stress induced by arsenite and therefore centers TgHoDI as a
player in stress response.
The alterations in granule formation as the consequence of chemical treatments
suggest TgHoDI is able to participate in translational repression during environmental
stress. As shown in Figure 3.2 (lower illustration) the presence of distinct foci in
untreated extracellular parasites is indicative of the shutdown of active translation and the
formation of stress granules. Toxoplasma is an obligate intracellular organism incapable
of surviving for extended periods outside of a host [1]. Also, the apparent dispersed
localization of TgHoDI in intracellular parasite, which is similar to cycloheximide treated
parasites, suggests the absence of translational repression with transcripts becoming
incorporated into the polysome. Arsenite treatment has been shown to inhibit translation
and induce the formation of stress granules. The exposure to arsenite causes a greater
stress response, which lead to the increase in both TgHoDI and mRNA granule size and
number. Together, these results suggest that TgHoDI participates in the formation of
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stress granules when translation is arrested. However, it cannot be ruled out that TgHoDI
may also functions in processing bodies. The presence of TgHoDI in intracellular
tachyzoites and the incomplete colocalization with PABP in extracellular parasites
suggests this second function of TgHoDI within the cytoplasm. Therefore, subsequent
experiments must be performed to determine the involvement of TgHoDI in these
granules.
The findings of this study strongly suggests the presence of a conserved posttranscriptional mechanism in Toxoplasma involving TgHoDI. As shown in Figure 3.2
(upper illustration), active translation can be halted by either environmental stress
(extracellular parasites) or chemical treatment (arsenite) leading to the formation of stress
granules. Also, treatments inducing the stalling of translation machinery (i.e. CHX) leads
to the dissociation of stress granules and processing bodies by the trapping of mRNA in
the polysome. Furthermore, the findings have shown that the composition of these
aggregates are indicative of the fate of mRNA associated in them. This study is the first
to characterize such a mechanism is Toxoplasma and provides the framework for future
studies to identify the mechanisms involved in stress response and tachyzoite-bradyzoite
differentiation.
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Figure 3.2 Identified mechanism for post-transcriptional gene regulation in T. gondii
(Top) A general outline of the identified mechanism for post-transcriptional
regulation of mRNA. mRNAs can be involved in either active translation (polysome),
storage (stress granules) or degradation (processing bodies). Chemical treatments cause a
shift of mRNA localization from one sub-cellular structure to another. The composition
of these structures dictates the fate of mRNA involved. Double strike through indicates a
lack of component present in the structure. (Bottom) Summary of IFA observations of
this study. The localization of TgHoDI, which has been identified as a member in
mechanisms of stress response, is altered in the different parasite strains and under the
treatment of cycloheximide and arsenite.
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A hallmark experiment in the analysis of newly identified DEAD-box RNA
helicases is to determine whether the protein is capable of complementing the TS- growth
defect of Δdhh1 cells. TgHoDI partially rescued yeast cell growth at 24 hours, validating
its function in stress response. After 36 hours complementation appears to occur to a
greater extent which may signify the necessity of increased incubation periods for full
complementation to occur. However, the expression of TgHoDI from the strong GPD
promoter exemplifies that TgHoDI is required at greater levels in comparison to Dhh1 to
complement growth (Fig.2.15). The necessary increase in both incubation time and
TgHoDI levels required for complete complementation may suggest that TgHoDI
functions in a similar, but not identical, cellular stress response mechanism as Dhh1.
Many proteins have been shown to function in stress-specific mechanisms, therefore
there is a possibility that TgHoDI is incapable of fully functioning in temperature induced
stress [81]. In addition, the variation in TgHoDI's ability to complement the TSphenotype may be an indication of post-translational modifications, such as
phosphorylation. The expression of TgHoDI, which has three possible phosphorylation
sites, in yeast would influence the occurrence of these modifications leading to possible
alterations in protein function. Similarly, TgHoDI may require Toxoplasma specific
factors which may enable proper function to occur. Taken as a whole, TgHoDI has been
implicated in post-transcriptional regulation during stress response as a functional
analogue to Dhh1 in yeast.
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CHAPTER IV
Concluding Remarks and Future Directions
DEAD-box RNA helicases are highly conserved proteins which have been
implicated in almost all aspects of RNA metabolism in organisms ranging from yeast to
complex eukaryotes. However, in Toxoplasma gondii the function of these proteins have
not yet been studied. Their implications in post-transcriptional gene regulation remains
unknown. The study of DEAD-box RNA helicases may provide the information
necessary to reveal how these mechanisms function in post-transcriptional regulation and
translational repression.
The current study has provided significant insight into the involvement of
TgHoDI in the regulation of mRNA during stress response. This findings show that
TgHoDI is a component in stress granules and capable of functioning in a similar manner
as the DEAD-box protein Dhh1 in yeast. TgHoDI localization is dynamic and reflects its
possible participation in post-transcriptional gene regulation. This study strongly suggests
the presence of conserved mechanisms regulating the availability of transcripts between
translational machinery and sub-cellular structures (SGs and PBs). These mechanisms are
vital in stress mediated repression of mRNA as well as tachyzoite-bradyzoite
differentiation. Future work should be performed to determine how TgHoDI expression
may affect the stress-induced response in Toxoplasma. It will be interesting to determine
if the abolishment or over expression of TgHoDI protein will alter the ability of parasites
to respond to cellular stress. Furthermore, these studies may have implications in the
stage-specific repression of transcripts and therefore may shed light on the mechanisms
behind tachyzoite-bradyzoite differentiation. For this to occur, it will be necessary to
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determine the involvement of TgHoDI with specific mRNAs and therefore alterations in
mRNA levels can be analyzed as a function of TgHoDI expression. In accordance with
this, it will be vital to investigate the regulation of total mRNA populations at various
levels of TgHoDI expression. The ability of TgHoDI to regulate mRNA in both the
sexual and asexual parasitic life stages may further allow for the characterization of
protein function. The homologue of TgHoDI in Plasmodium was determined to play a
larger role in the sexual component of the parasitic life cycle which may suggest the
involvement of TgHoDI in the sexual stage of Toxoplasma.
Other studies must be performed to determine if TgHoDI localization is altered as
a function of various environmental stresses. It has been shown that the composition of
cytosolic granules changes according to variable stress conditions. It will be necessary to
determine the involvement of TgHoDI within these granules during stresses such as
nutrient deprivation, temperature variations and several chemical treatments. This will
clarify the function of TgHoDI as a central player in a universal mechanism of stress
response or a stress-specific response. Furthermore, these colocalization studies must be
performed with markers of not only stress granules, but also processing bodies (i.e.
Dcp1a). The presence of TgHoDI during the various life stages and treatments in this
study suggest a second function which may be implicated in p-body formation.
Moreover, in vitro studies analyzing the function of TgHoDI in RNA unwinding
will validate its involvement in mRNP remodeling. However, prior to these studies it may
be necessary to determine if post-translational protein modifications such as
phosphorylation alter protein function.
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CHAPTER V - METHODS
* For materials, please see Appendix B.
5.1 Plasmid construction
pSF-TAP-LIC-HX-Dozi and pYFP-LIC-HX-Dozi
Standard protocol for ligation independent cloning was performed as previously
described [82]. To produce clonal parasites with endogenous C-terminal tagging of the
TgHoDI protein, a 2.8 Kb genomic sequence of TgHoDI (Toxodb gene ID #
TggT1_089230; chrXI: 5,292-8,058) was PCR amplified from the ∆Ku80 genome using
the oligonucleotide primers TgDozi.LIC.F and TgDozi.LIC.R (Appendix B). This
product was T4 DNA polymerase treated to create a 15 base pair 5’ overhang by means
of 3’to 5’ exonuclease activity. The pYFP-LIC-HX and pSF-TAP-LIC-HX vectors were
linearized using PacI restriction endonuclease, T4 DNA polymerase treated and gel
purified. The PCR fragment was cloned into the linearized vectors with the resultant
plasmids transformed into E.coli cells and subjected to colony PCR using the
TgDozi.LIC.F and TgDozi.LIC.R oligonucleotides. Plasmid confirmation was performed
by EcoRI and PvuII restriction endonuclease analyses (see plasmid maps, Appendix C).
HoDI-S-DD-F LIC-HX
To produce clonal parasites with endogenous C-terminal tagging of the TgHoDI
protein with the ddFKBP, PCR analysis was performed to amplify the CDS of ddFKBP
from pCAG-EGFpd2 plasmid using the oligonucleotide primers cf_FW_S_DD_F and
cf_FW_S_DD_R (Appendix B). The plasmid expressing HoDI-SF (pSF-TAP-LIC-HXDozi) was digested with SfoI which produced a single cut in between the streptavidin and
FLAG tags. The ddFKBP product was then introduced into the linearized pSF-TAP-LICHX-Dozi plasmid via the cold fusion method of cloning. This allowed for the CDS of
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ddFKBP to be flanked by the Strep and FLAG tags. Plasmid confirmation was performed
by ApaLI, PstI and PvuII restriction endonuclease analyses (see plasmid maps, Appendix
C).
pRS424-GPD_TgDozi plasmid
To place the expression of TgHoDI under the control of the glyceraldehyde-3phosphate dehydrogenase (GPD) promoter for complementation studies in S. cerevisiae,
the open reading frame of TgHoDI was excised from the pET-28b_TgDozi expression
plasmid by NcoI digestion followed by Klenow Fragment treatment to produce a 5’ blunt
end. Linearized vector was then digested with XhoI and gel extracted. In the preparation
of the pRS424-GPD plasmid the vector was digested with NcoI, phenol: chloroform
extracted and digested with SmaI. The fragment was cloned into the linearized vector and
the resultant pRS424-GPD_TgDozi plasmid was subjected to HincII and NdeI restriction
endonuclease analyses.
5.2 Cell and Parasite Culture
Human Foreskin Fibroblasts
Human foreskin fibroblasts were maintained using Dulbecco's Modified Eagle
Medium (DMEM) with 25 mM D-glucose and 4 mM L-glutamine supplemented with
10% cosmic calf and 0.5x antibiotic-antimycotic at 37oC in 5% CO2.
T. gondii
Two strains of T. gondii, RH∆HX and ∆Ku80, were cultured in confluent human
foreskin fibroblasts (HFF) using Minimal Essential Media Eagle (MEM), supplemented
with 1% dialyzed fetal bovine serum (dFBS) and 0.5x antibiotic-antimycotic.
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Transgenic parasites, TgHoDI-SF and TgHoDI-YFP, were cultured in MEM
supplemented with 1% dFBS, 2.5x antibiotic-antimycotic, 25 mg/mL myocophenolic
acid and 25 mg/mL xanthine.
5.3 Transformation of microorganisms
E. coli
Standard protocol performed as previously described [83]. XL1-Blue competent
cells were incubated with plasmid DNA on ice for 30 minutes. The cells were then heat
shocked at 42oC for 45 seconds and incubated on ice for 2 minutes. Cells were then
combined with 500 µL of Super Optimal Broth with catabolite-repression (SOC Medium)
and incubated at 37oC for 1 hour with agitation. An appropriate amount of transformation
mixtures was then plated on an Luria Bertani (LB) agar plate with appropriate antibiotic
and grown at 37oC overnight.
T. gondii
Standard protocol performed as previously described [84]. Freshly lysed ∆Ku80
parasites (~ 2 x 106 parasites) were used for each transfection via electroporation using a
BTX ECM 630 (1500 volts, 25 Ω, and 25 μF). For each transfection, 20 µg of expression
plasmids encoding pSF-TAP-LIC-HX-TgDozi or pYFP-LIC-HX-TgDozi were linearized
with PflmI and PmeI, respectively, mixed with harvested parasites in a 400 µL
electroporation mixture and electroporated in a 4 mm-gap cuvette. Following
electroporation, the parasites were cultured in confluent HFF monolayers grown using
MEM with 1% dFBS and antibiotic-antimycotic at 37oC in 5% CO2. Transgenic parasites
were then selected for with MEM supplemented with 1% dFBS, 0.5x antibioticantimycotic, 25 mg/mL myocophenolic acid and 25 mg/mL xanthine. Clonal parasites
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were then isolated by serial dilution in 96 well plates to obtain a clonal population [84].
Transgenic populations were confirmed by PCR and Western blot analysis.
S. cerevisiae
Standard lithium acetate transformation protocol was performed as previously
described [83]. Wild-type yeast and YTC444 were grown on YAPD and Leu- synthetic
drop-out plates, for the WT and YTC444 respectively, and colonies were selected and
grown overnight at 30oC in YAPD media with agitation. YTC444 yeast was transformed
with p414PromDhh1and pRS424-GPD_TgDozi, for expression of Dhh1 and TgHoDI,
respectively. Salmon sperm DNA was incubated at 90oC for 3 minutes, quenched on ice
for 2 minutes and combined with 500 µL of plate solution. The solution was then
combined with yeast cells and ~1 µg of expression plasmid, mixed and incubated
overnight at room temperature. Cell suspensions were then centrifuged at 2,000 rpm for 1
minute and cells were re-suspended in 300 µL of 1x TE. An appropriate amount of
transformation was then spread onto Leu-/Trp- plates and incubated at 30oC for 2-4 days.
5.4 Immunological detection methods
Western Blot
Standard protocol as previously described [83]. Lysates of T. gondii parasites
were prepared by addition of 50 µL of RIPA buffer, sonication for 5 seconds and
incubation on ice. Protein concentration was measured using the RC DC Protein Assay
according to manufacturer’s instructions (Bio-Rad Laboratories, Cat #500-0119) and
absorbance values were taken at 750 nm on the Genesys 10 UV/Visible
spectrophotometer. Lysates were denatured using 6x SDS protein loading dye and
resolved on a 10% SDS-PAGE for 1 hour and subsequently transferred to a nitrocellulose
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membrane. Following transfer, nitrocellulose blots were blocked with 5% (w/v) non-fat
skim milk in TBST for a minimum of 30 minutes and incubated with primary antibodies
in 2% (w/v) non-fat skim milk in TBST for 1 hour. The primary antibodies used were:
mouse anti-Tub (1:5,000), mouse anti-FLAG (1:5,000), rabbit anti-LDH1 (1:2,000), and
goat anti-GFP (1:2,500) (Appendix B). Blots were subsequently washed 3 times for 5
minutes with TBST and incubated with specific secondary antibodies for 1 hour. The
secondary antibodies used were: horseradish peroxidase (HRP)-goat anti-mouse
(1:10,000), HRP-rabbit anti-goat (1:10,000), HRP-goat anti-rabbit (1:10,000). Finally,
blots were washed, incubated with Chemiluminescent HRP Substrate Kit (Millipore) and
visualized using the FluorChem Q Imager (Alpha Innotech) with AlphaView-FluorChem
Q software.
Immunofluorescence Assay
HFF monolayers were cultured on coverslips until confluent, infected with ~1 x
106 freshly lysed parasites and incubated at 37oC and 5% CO2 for 24 hours. Cells were
rinsed three times in 1x (v/v) phosphate buffer saline (PBS), fixed with 3% (w/v)
paraformaldehyde for 5 minutes and permeabilized with 0.25% Triton X-100 in PBS for
10 minutes. Coverslips were then washed in 1x PBS and subsequently incubated in a
blocking solution of 5% (w/v) bovine serum albumin (BSA) in PBS with gentle agitation
for 1 hour at room temperature. Coverslips were then incubated for 1 hour in a humidity
chamber with a specific primary antibody diluted in 2% (w/v) BSA. The primary
antibodies used were: mouse anti-FLAG (1:500) and rabbit anti-PABPC3 (1:500). Cells
were once again washed in 1x PBS and incubated for 1 hour with secondary antibody
diluted in 2% (w/v) BSA. The secondary antibodies used were: Rhodamine (Rho)-
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conjugated goat anti-rabbit (1:500) and Rho-conjugated goat anti-mouse (1:500). Cells
were then stained with Hoechst stain (100 μM) at room temperature, washed twice with
1x PBS and mounted on glass slides with fluoromount. Imaging was performed on a
Leica DMI 6000B inverted fluorescent microscope using HCX PL Apo 100x/1.40-0.70
objective and a Leica DFC 360FX camera in addition to the Leica Application Software
(LAS). Confocal imaging was performed on an Olympus 1X81 inverted microscope
using Plan Apo-N 60x/1.42 oil objective outfitted with Fluoview 1000 imagine system.
Post-acquisition image processing was performed with Adobe Photoshop 7.0.
For extracellular T. gondii, ~ 1 x 106 freshly lysed parasites were incubated on
coverslips at 37oC and 5% CO2 and allowed to adhere for 1 hour. Coverslips were rinsed
in 1x (v/v) PBS and fixed/permeabilized at 4°C with ice cold methanol for 10 minutes.
The remaining protocol was as previously described. Fluorescence in situ Hybridization
Freshly lysed parasites (~ 1 x 106) were transferred on coverslips at 37oC and 5%
CO2 and allowed to adhere for 1 hour. Coverslips were washed 1x (v/v) PBS and
fixed/permeabilized at 4°C with ice cold methanol for 10 minutes. Parasites were rinsed
with 2x SSC buffer 2 times for 10 minutes and incubated with hybridization buffer,
~400ng biotin labeled oligo-dT50 and deionized formamide in a humidity chamber
overnight at 37oC. The coverslips were then washed 2 times with 2x SSC for 30 minutes
and 1 time in 0.5X SSC for 15 minutes. Parasites were then incubated for 60 minutes at
room temperature in Rho-conjugated streptavidin (1:500) in 4x SSC in a humidified
chamber. Coverslips were then washed with 2 times with 4x SSC for 10 minutes and 1
time in 4x SSC with 0.01% Triton X-100. Finally, coverslips were stained with Hoechst
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stain (100 μM) at room temperature, washed twice with 4X SSC for 5 minutes and
mounted on glass slides with fluoromount.
5.5 Assays for functional analysis
Drug treatment
For extracellular T. gondii, ~ 1 x 106 freshly lysed parasites were incubated on
coverslips at 37oC and 5% CO2 and allowed to adhere for 1 hour. Parasites were pretreated with either 50 µg/mL cycloheximide or 10 µM sodium m-arsenite. Subsequent
IFA and FISH analysis were performed as previously stated.
S. cerevisiae ∆dhh1 Complementation and Growth
To determine the ability of TgHoDI to functionally complement the temperature
dependence of the YTC444 yeast strain, transformed cells were grown in 4 mL of YAPD
media and incubated overnight at 30oC with agitation. For the expression of Dhh1, cells
were transformed with a low copy centromeric plasmid expressing Dhh1 from its
endogenous promoter. For the expression of TgHoDI, cells were transformed with a high
copy number plasmid (2µm) expressing TgHoDI under the strong yeast GPD promoter.
The optical density (OD) was then taken at 600 nm to confirm cells were in the mid-log
phase of growth. Cells were subsequently diluted to an OD of ~0.5. Serial dilutions were
performed using sterile 1X TE and 3 µL of each dilution was spotted onto YPAD plates.
Plates were then incubated upright at 30oC and 37oC for 2 days.

87

REFERENCES
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.

Weiss, L.M. and K. Kim, Toxoplasma gondii: The model apicomplexan.
Perspectives and methods. 2011: Academic Press.
Donald, R.G. and D.S. Roos, Gene knock-outs and allelic replacements in
Toxoplasma gondii: HXGPRT as a selectable marker for hit-and-run
mutagenesis. Mol Biochem Parasitol, 1998. 91(2): p. 295-305.
Black, M.W. and J.C. Boothroyd, Lytic cycle of Toxoplasma gondii. Microbiol
Mol Biol Rev, 2000. 64(3): p. 607-23.
Dubey, J.P., D.S. Lindsay, and C.A. Speer, Structures of Toxoplasma gondii
tachyzoites, bradyzoites, and sporozoites and biology and development of tissue
cysts. Clin Microbiol Rev, 1998. 11(2): p. 267-99.
Radke, J.R., et al., Defining the cell cycle for the tachyzoite stage of Toxoplasma
gondii. Mol Biochem Parasitol, 2001. 115(2): p. 165-75.
Montoya, J.G. and O. Liesenfeld, Toxoplasmosis. Lancet, 2004. 363(9425): p.
1965-76.
Saeij, J.P., J.P. Boyle, and J.C. Boothroyd, Differences among the three major
strains of Toxoplasma gondii and their specific interactions with the infected host.
Trends Parasitol, 2005. 21(10): p. 476-81.
David Sibley, L., Recent origins among ancient parasites. Vet Parasitol, 2003.
115(2): p. 185-98.
Khan, A., et al., Genotyping of Toxoplasma gondii strains from
immunocompromised patients reveals high prevalence of type I strains. J Clin
Microbiol, 2005. 43(12): p. 5881-7.
Sibley, L.D. and J.C. Boothroyd, Virulent strains of Toxoplasma gondii comprise
a single clonal lineage. Nature, 1992. 359(6390): p. 82-5.
Howe, D.K. and L.D. Sibley, Toxoplasma gondii comprises three clonal lineages:
correlation of parasite genotype with human disease. J Infect Dis, 1995. 172(6):
p. 1561-6.
Cristina, N., et al., A DNA fingerprinting method for individual characterization
of Toxoplasma gondii strains: combination with isoenzymatic characters for
determination of linkage groups. Parasitol Res, 1995. 81(1): p. 32-7.
Su, C., X. Zhang, and J.P. Dubey, Genotyping of Toxoplasma gondii by
multilocus PCR-RFLP markers: a high resolution and simple method for
identification of parasites. Int J Parasitol, 2006. 36(7): p. 841-8.
Kissinger, J.C., et al., ToxoDB: accessing the Toxoplasma gondii genome.
Nucleic Acids Res, 2003. 31(1): p. 234-6.
Gajria, B., et al., ToxoDB: an integrated Toxoplasma gondii database resource.
Nucleic Acids Res, 2008. 36(Database issue): p. D553-6.
Howe, D.K., B.C. Summers, and L.D. Sibley, Acute virulence in mice is
associated with markers on chromosome VIII in Toxoplasma gondii. Infect
Immun, 1996. 64(12): p. 5193-8.
Grigg, M.E. and J.C. Boothroyd, Rapid identification of virulent type I strains of
the protozoan pathogen Toxoplasma gondii by PCR-restriction fragment length
polymorphism analysis at the B1 gene. J Clin Microbiol, 2001. 39(1): p. 398-400.

88

18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.

Howe, D.K., et al., Determination of genotypes of Toxoplasma gondii strains
isolated from patients with toxoplasmosis. J Clin Microbiol, 1997. 35(6): p. 14114.
Ajzenberg, D., et al., Genotype of 86 Toxoplasma gondii isolates associated with
human congenital toxoplasmosis, and correlation with clinical findings. J Infect
Dis, 2002. 186(5): p. 684-9.
Madi, D., et al., Successful treatment of cerebral toxoplasmosis with clindamycin:
a case report. Oman Med J, 2012. 27(5): p. 411-2.
Halbeisen, R.E., et al., Post-transcriptional gene regulation: from genome-wide
studies to principles. Cell Mol Life Sci, 2008. 65(5): p. 798-813.
Lee, T.I. and R.A. Young, Transcription of eukaryotic protein-coding genes.
Annu Rev Genet, 2000. 34: p. 77-137.
Nathan, D., D.E. Sterner, and S.L. Berger, Histone modifications: Now
summoning sumoylation. Proc Natl Acad Sci U S A, 2003. 100(23): p. 13118-20.
Soldati, D. and J.C. Boothroyd, A selector of transcription initiation in the
protozoan parasite Toxoplasma gondii. Mol Cell Biol, 1995. 15(1): p. 87-93.
Latchman, D.S., Transcription factors: an overview. Int J Biochem Cell Biol,
1997. 29(12): p. 1305-12.
Gissot, M., et al., PfMyb1, a Plasmodium falciparum transcription factor, is
required for intra-erythrocytic growth and controls key genes for cell cycle
regulation. J Mol Biol, 2005. 346(1): p. 29-42.
Proudfoot, N.J., A. Furger, and M.J. Dye, Integrating mRNA processing with
transcription. Cell, 2002. 108(4): p. 501-12.
Erickson, S.L. and J. Lykke-Andersen, Cytoplasmic mRNP granules at a glance. J
Cell Sci, 2011. 124(Pt 3): p. 293-7.
Parker, R. and U. Sheth, P bodies and the control of mRNA translation and
degradation. Mol Cell, 2007. 25(5): p. 635-46.
Hooper, C. and A. Hilliker, Packing them up and dusting them off: RNA helicases
and mRNA storage. Biochim Biophys Acta, 2013.
Lopez-Lastra, M., A. Rivas, and M.I. Barria, Protein synthesis in eukaryotes: the
growing biological relevance of cap-independent translation initiation. Biol Res,
2005. 38(2-3): p. 121-46.
Balagopal, V. and R. Parker, Polysomes, P bodies and stress granules: states and
fates of eukaryotic mRNAs. Curr Opin Cell Biol, 2009. 21(3): p. 403-8.
Coller, J. and R. Parker, Eukaryotic mRNA decapping. Annu Rev Biochem, 2004.
73: p. 861-90.
Parker, R. and H. Song, The enzymes and control of eukaryotic mRNA turnover.
Nat Struct Mol Biol, 2004. 11(2): p. 121-7.
van Dijk, E., et al., Human Dcp2: a catalytically active mRNA decapping enzyme
located in specific cytoplasmic structures. EMBO J, 2002. 21(24): p. 6915-24.
Wilusz, C.J., et al., Poly(A)-binding proteins regulate both mRNA deadenylation
and decapping in yeast cytoplasmic extracts. RNA, 2001. 7(10): p. 1416-24.
Khanna, R. and M. Kiledjian, Poly(A)-binding-protein-mediated regulation of
hDcp2 decapping in vitro. EMBO J, 2004. 23(9): p. 1968-76.

89

38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.

Tharun, S. and R. Parker, Targeting an mRNA for decapping: displacement of
translation factors and association of the Lsm1p-7p complex on deadenylated
yeast mRNAs. Mol Cell, 2001. 8(5): p. 1075-83.
Coller, J.M., et al., The DEAD box helicase, Dhh1p, functions in mRNA
decapping and interacts with both the decapping and deadenylase complexes.
RNA, 2001. 7(12): p. 1717-27.
Cougot, N., S. Babajko, and B. Seraphin, Cytoplasmic foci are sites of mRNA
decay in human cells. J Cell Biol, 2004. 165(1): p. 31-40.
Eulalio, A., I. Behm-Ansmant, and E. Izaurralde, P bodies: at the crossroads of
post-transcriptional pathways. Nat Rev Mol Cell Biol, 2007. 8(1): p. 9-22.
Anderson, P. and N. Kedersha, Stress granules: the Tao of RNA triage. Trends
Biochem Sci, 2008. 33(3): p. 141-50.
Patel, S.S. and I. Donmez, Mechanisms of helicases. J Biol Chem, 2006. 281(27):
p. 18265-8.
Singleton, M.R., M.S. Dillingham, and D.B. Wigley, Structure and mechanism of
helicases and nucleic acid translocases. Annu Rev Biochem, 2007. 76: p. 23-50.
Russell, R., I. Jarmoskaite, and A.M. Lambowitz, Toward a molecular
understanding of RNA remodeling by DEAD-box proteins. RNA Biol, 2013.
10(1): p. 44-55.
Ye, J., et al., RecA-like motor ATPases--lessons from structures. Biochim Biophys
Acta, 2004. 1659(1): p. 1-18.
Gorbalenya, A.E., E.V. Koonin, and Y.I. Wolf, A new superfamily of putative
NTP-binding domains encoded by genomes of small DNA and RNA viruses. FEBS
Lett, 1990. 262(1): p. 145-8.
Snider, J., G. Thibault, and W.A. Houry, The AAA+ superfamily of functionally
diverse proteins. Genome Biol, 2008. 9(4): p. 216.
Neuwald, A.F., et al., AAA+: A class of chaperone-like ATPases associated with
the assembly, operation, and disassembly of protein complexes. Genome Res,
1999. 9(1): p. 27-43.
Ogura, T. and A.J. Wilkinson, AAA+ superfamily ATPases: common structure-diverse function. Genes Cells, 2001. 6(7): p. 575-97.
Iyer, L.M., et al., Evolutionary history and higher order classification of AAA+
ATPases. J Struct Biol, 2004. 146(1-2): p. 11-31.
Labib, K., J.A. Tercero, and J.F. Diffley, Uninterrupted MCM2-7 function
required for DNA replication fork progression. Science, 2000. 288(5471): p.
1643-7.
Fairman-Williams, M.E., U.P. Guenther, and E. Jankowsky, SF1 and SF2
helicases: family matters. Curr Opin Struct Biol, 2010. 20(3): p. 313-24.
Linder, P. and P. Lasko, Bent out of shape: RNA unwinding by the DEAD-box
helicase Vasa. Cell, 2006. 125(2): p. 219-21.
Linder, P. and E. Jankowsky, From unwinding to clamping - the DEAD box RNA
helicase family. Nat Rev Mol Cell Biol, 2011. 12(8): p. 505-16.
Cordin, O., et al., The DEAD-box protein family of RNA helicases. Gene, 2006.
367: p. 17-37.

90

57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.

Gorbalenya, A.E., et al., Two related superfamilies of putative helicases involved
in replication, recombination, repair and expression of DNA and RNA genomes.
Nucleic Acids Res, 1989. 17(12): p. 4713-30.
Linder, P., Dead-box proteins: a family affair--active and passive players in RNPremodeling. Nucleic Acids Res, 2006. 34(15): p. 4168-80.
Yang, Q., et al., DEAD-box proteins unwind duplexes by local strand separation.
Mol Cell, 2007. 28(2): p. 253-63.
Liu, F., A. Putnam, and E. Jankowsky, ATP hydrolysis is required for DEAD-box
protein recycling but not for duplex unwinding. Proc Natl Acad Sci U S A, 2008.
105(51): p. 20209-14.
Bleichert, F. and S.J. Baserga, The long unwinding road of RNA helicases. Mol
Cell, 2007. 27(3): p. 339-52.
Tanner, N.K., et al., The Q motif: a newly identified motif in DEAD box helicases
may regulate ATP binding and hydrolysis. Mol Cell, 2003. 11(1): p. 127-38.
Rocak, S. and P. Linder, DEAD-box proteins: the driving forces behind RNA
metabolism. Nat Rev Mol Cell Biol, 2004. 5(3): p. 232-41.
Schwer, B. and T. Meszaros, RNA helicase dynamics in pre-mRNA splicing.
EMBO J, 2000. 19(23): p. 6582-91.
Tseng-Rogenski, S.S., et al., Functional conservation of Dhh1p, a cytoplasmic
DExD/H-box protein present in large complexes. Nucleic Acids Res, 2003.
31(17): p. 4995-5002.
Buchan, J.R., D. Muhlrad, and R. Parker, P bodies promote stress granule
assembly in Saccharomyces cerevisiae. J Cell Biol, 2008. 183(3): p. 441-55.
Rajyaguru, P. and R. Parker, CGH-1 and the control of maternal mRNAs. Trends
Cell Biol, 2009. 19(1): p. 24-8.
Mair, G.R., et al., Regulation of sexual development of Plasmodium by
translational repression. Science, 2006. 313(5787): p. 667-9.
Mair, G.R., et al., Universal features of post-transcriptional gene regulation are
critical for Plasmodium zygote development. PLoS Pathog, 2010. 6(2): p.
e1000767.
Sievers, F., et al., Fast, scalable generation of high-quality protein multiple
sequence alignments using Clustal Omega. Mol Syst Biol, 2011. 7: p. 539.
Braun, L., et al., A complex small RNA repertoire is generated by a plant/fungallike machinery and effected by a metazoan-like Argonaute in the single-cell
human parasite Toxoplasma gondii. PLoS Pathog, 2010. 6(5): p. e1000920.
Al Riyahi, A., et al., Single argonaute protein from Toxoplasma gondii is involved
in the double-stranded RNA induced gene silencing. Int J Parasitol, 2006. 36(9):
p. 1003-14.
Huynh, M.H. and V.B. Carruthers, Tagging of endogenous genes in a Toxoplasma
gondii strain lacking Ku80. Eukaryot Cell, 2009. 8(4): p. 530-9.
Banaszynski, L.A., et al., A rapid, reversible, and tunable method to regulate
protein function in living cells using synthetic small molecules. Cell, 2006.
126(5): p. 995-1004.
Lirussi, D. and M. Matrajt, RNA granules present only in extracellular
toxoplasma gondii increase parasite viability. Int J Biol Sci, 2011. 7(7): p. 960-7.

91

76.
77.
78.
79.
80.
81.
82.
83.
84.

Anderson, P. and N. Kedersha, Stress granules. Curr Biol, 2009. 19(10): p. R3978.
Mollet, S., et al., Translationally repressed mRNA transiently cycles through
stress granules during stress. Mol Biol Cell, 2008. 19(10): p. 4469-79.
Kedersha, N., et al., Dynamic shuttling of TIA-1 accompanies the recruitment of
mRNA to mammalian stress granules. J Cell Biol, 2000. 151(6): p. 1257-68.
Bodenmiller, B., et al., PhosphoPep[mdash]a phosphoproteome resource for
systems biology research in Drosophila Kc167 cells. Mol Syst Biol, 2007. 3.
Zhang, M., et al., Translational control in Plasmodium and toxoplasma parasites.
Eukaryot Cell, 2013. 12(2): p. 161-7.
Dewey, C.M., et al., TDP-43 is directed to stress granules by sorbitol, a novel
physiological osmotic and oxidative stressor. Mol Cell Biol, 2011. 31(5): p. 1098108.
Novy, R., K. Yaeger, and K. Kolb, Ligation independent cloning: efficient
directional cloning of PCR products. InNovations, 1996. 5: p. 1-3.
Sambrook, J., E.F. Fritsch, and T. Maniatis, Molecular cloning. Vol. 2. 1989:
Cold spring harbor laboratory press New York.
Soldati, D. and J.C. Boothroyd, Transient transfection and expression in the
obligate intracellular parasite Toxoplasma gondii. Science, 1993. 260(5106): p.
349-52.

92

APPENDIX A
Name of Gene
DEAD/DEAH box helicase, putative
ATP-dependent helicase / DEAD, putative
DEAD/DEAH box helicase, putative
DEAD/DEAH box helicase, putative
DEAD-box helicase family protein
DEAD/DEAH box helicase, putative
DEAD/DEAH box helicase, putative
DEAD/DEAH box helicase, putative
DEAD/DEAH box helicase, putative
DEAD/DEAH box helicase, putative
DEAD/DEAH box helicase, putative
DEAD/DEAH box helicase, putative
DEAD RNA helicase, putative
DEAD/DEAH box helicase, putative
DEAD/DEAH box helicase, putative
DEAD/DEAH box helicase, putative
DEAD/DEAH box helicase, putative
DEAD/DEAH box RNA helicase, putative
ATP-dependent RNA helicase, putative
ATP-dependent RNA helicase, putative
helicase, putative
ATP-dependent helicase, putaive, putative
ATP-dependent RNA helicase, putative
ATP-dependent RNA helicase, putative
ATP-dependent RNA helicase, putative
ATP-dependent RNA helicase, putative
ATP-dependent RNA helicase, putative
ATP-dependent RNA helicase, putative
ATP-dependent DNA helicase, putative
ATP-dependent RNA helicase, putative
Helicase, putative
ATP-dependent RNA helicase, putative
Helicase, putative
ATP-dependent RNA helicase, putative
RNA helicase, putative
RNA helicase, putative
ATP-dependent RNA helicase, putative
ATP-dependent RNA helicase, putative
ATP-dependent DNA helicase, putative
ATP-dependent RNA helicase, putative
RNA helicase, putative

Chr.
1a
1b
II
II
II
IX
IX
V
VI
VI
VIIb
VIIb
X
X
X
XI
XI
XII
1b
II
VIIa
VIIb
VIII
X
XI
XI
XI
1a
Ib
III
IV
IX
IX
1a
IX
VIIa
VIIb
VIIb
VIIb
VIIb
VIII
93

Accession
Number
TGGT1_074650
TGGT1_020410
TGGT1_065970
TGGT1_053690
TGGT1_096090
TGGT1_053270
TGGT1_041270
TGGT1_037060
TGGT1_049520
TGGT1_045960
TGGT1_009750
TGGT1_013850
TGGT1_081240
TGGT1_077470
TGGT1_069190
TGGT1_089630
TGGT1_093990
TGGT1_030160
TGGT1_021570
TGGT1_065520
TGGT1_016870
TGGT1_013990
TGGT1_109180
TGGT1_081400
TGGT1_089210
TGGT1_089230
TGGT1_098270
TGGT1_075360
TGGT1_021870
TGGT1_002060
TGGT1_123390
TGGT1_056640
TGGT1_075910
TGGT1_075360
TGGT1_031770
TGGT1_063370
TGGT1_044400
TGGT1_044050
TGGT1_010560
TGGT1_010590
TGGT1_106360

Molecular
Weight
273737 Da
81975 Da
139953 Da
61270Da
130939 Da
73199 Da
175200 Da
145819 Da
156895 Da
111689 Da
172792 Da
202672 Da
130943 Da
238791 Da
59939 Da
74805 Da
103253 Da
107394 Da
107244 Da
169171 Da
189156 Da
45127 Da
105362 Da
78594 Da
63848 Da
53462 Da
49115 Da
77076 Da
115676 Da
71697 Da
115949 Da
99433 Da
299694 Da
77076 Da
74705 Da
116139 Da
88822 Da
116099 Da
98394 Da
97328 Da
43728 Da

ATP-dependent RNA helicase, putative
ATP-dependent RNA helicase, putative
DEAH-box RNA/DNA helicase, putative
DEAH-box RNA/DNA helicase, putative

X
XII
IV
V

TGGT1_077510
TGGT1_102880
TGGT1_122680
TGGT1_035990

174755 Da
121538 Da
236964 Da
241922 Da

Table A1 DEAD-box and ATP dependent RNA helicases in Toxoplasma
Bioinformatic analysis of Dead-box and ATP dependent RNA helicases in T.
gondii using Toxodb Database [15]. Analyses identified 20 putative proteins with high
sequence homology to the DEAD-box RNA helicases with another 26 possible ATP
dependent RNA helicases. The chromosomal location, gene ID (in type I strain) and
molecular weight are shown.
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APPENDIX B
Buffers and Solutions
Electroporation mixture
Radioimmunoprecipitation
assay buffer (RIPA)
6x SDS protein loading
dye
1x Tris-buffered saline
with Tween-20 (TBST)
20x Saline-sodium citrate
(SSC)
Hybridization buffer

Composition
120 mM KCl, 0.15 mM CaCl2, 10 mM K2HPO4/KH2PO4
(pH 7.6), 2 mM EDTA, 5 mM MgCl2, 2 mM ATP, 5 mM
glutathione.
25 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1% w/v Triton
X-100, 1% w/v sodium deoxycholate and 0.1% w/v SDS
12% w/v SDS, 0.06% w/v bromophenol blue, 47% v/v
glycerol, 6% v/v 1M Tris-pH 6.8 and 12.5% v/v βmercaptoethanol
68 mM NaCl, 8.3 mM Tris-base (pH 7.6) and 0.05% v/v
Tween-20
17.5% w/v NaCl, 9% w/v sodium citrate
25% v/v 20x SSC, 50% v/v 50% dextran sulfate, 25% v/v
yeast tRNA

Table B1 Buffers and their formula for various experiments in the study
The composition of buffers used in the study are shown with their corresponding
composition. These buffers vary in their application from parasite transformation, protein
lysate acquisition and FISH analyses.
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Antibody Against

Antisera
Name
α-Tub (12G10)
α-FLAG

Raised
in
Mouse
Mouse

Poly-A Binding Protein
C3
Green Fluorescent Protein

α-PABPC3

Rabbit

α-GFP

Goat

Lactate Dehydrogenase-1

α-LDH1

Rabbit

Bradyzoite Antigen-1

α-BAG1

Mouse

HRP α-Mouse

Goat

HRP α-Goat
HRP α-Rabbit
Rho α-Rabbit

Rabbit
Goat
Goat

Rho α-Mouse

Goat

Rho α-Goat
Rho α-Strep

Donkey
N/A

Alpha-Tubulin
D-tag (FLAG)

Horseradish peroxidase
(HRP) anti-mouse
HRP anti-goat
HRP anti-rabbit
Rhodamine-conjugated
(Rho) anti-rabbit
Rho-conjugated antimouse
Rho-conjugated anti-goat
Rho-conjugated
streptavidin

Obtained From
E.M. Nelsen; DSHB
Applied Biological Materials
(ABM) Inc. (#G191)
ABM Inc. (#Y058722)
Rockland (#17549)
Dr. Stephen Parmley; Palo
Alto Medical Foundation;
Calif.
Dr. Louis Weiss, Albert
Einstein College of Medicine,
N.Y
Rockland (#19072)
Rockland (#17320)
Rockland (#15949)
Rockland (#2495)
Rockland (#610-100-040)
Rockland (#3212)
Rockland (#22837)

Table B2 Antisera
Throughout this study, antisera were utilized in immunodetection studies such as
Western blot analysis, IFA and FISH. Antisera name, target protein and organism raised
in are present. Also, the company and catalog numbers are presented.
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Culture Material

Composition
Modifications. With: 25 mM glucose,
Dulbecco’s Modified
4 mM L-glutamine and 0.0399 mM
Eagle Media (DMEM)
phenol red. Without: sodium
pyruvate, HEPES and sodium
bicarbonate.
10000 units/mL penicillin, 10000
Antibiotic-Antimycotic
µg/mL streptomycin and 25 µg/mL
(100x)
amphotericin B.
Modifications. With: 2 mM LMinimum Essential Media glutamine and 0.0266 mM phenol red.
Eagle (MEM)
Without: HEPES and sodium
bicarbonate.
Yeast Extract Peptone
2% w/v bacto peptone, 1% w/v yeast
Dextrose with Adenine
extract, 2% w/v D-glucose, 2% w/v
(YPAD) plate Solution
bacto agar, 0.001% w/v adenine
90% w/v of 45% polyethylene glycol,
Yeast Plate solution
10% v/v 1M lithium acetate, 1% v/v
Tris-HCl pH 7.5 and 0.2% v/v 0.5M
EDTA
2% w/v bacto-tryptone, 0.5% w/v
Super Optimal Broth with bacto-yeast extract, 0.05% w/v NaCl,
catabolite repression
10 mM MgCl2, 2.5 mM KCl and 20
(SOC)
mM glucose.
1% w/v bacto-tryptone, 0.5% w/v
Luria-Burtani (LB) Agar
bacto-yeast, 1% w/v NaCl, 1 x 10-4 %
plate Solution
w/v antibiotic and 1.5% w/v bactoagar

Obtained From
Invitrogen (#12100046)

Invitrogen (#15240062)
Invitrogen
(#61100061)

N/A

N/A

N/A

N/A

Table B3 Culture Material
Various culture materials were required for growth of various microorganisms
used in the study. The name, composition and company (if applicable) are shown.
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Miscellaneous Materials
Xanthine
Mycophenolic acid
Sodium m-Arsenite
Cycloheximide
Cosmic Calf Serum (CCS)
Dialyzed Fetal Bovine serum
(dFBS)

Obtained From
Sigma (#X-3627)
Bio Basic Inc. (#24280-93)
Sigma (C7784-46-5)
Sigma (C7698-1G)
ThermoFisher Scientific; Hylcone (#H3008704N)
ThermoFisher Scientific; Hyclone (#SH3007903)

Table B4 Miscellaneous Materials for organism treatment
Material presented were used for the treatment of transgenic parasite clones as
well as to maintain HFF monolayers. Material name and acquisition company are shown.
Parasite/Yeast Strains
Human foreskin fibroblasts (HFF)
RH∆HX, T. gondii type I strain
∆Ku80 T. gondii
Wild-type yeast strain (MATa ade21, ura3-1, trp1-1, his3-11, leu2-3,112
can1-100)
YTC444 strain (MATa dhh1∆::LEU2
ade2-1, ura3-1, trp1-1, his3-11, leu23,112 can1-100)

Obtained From
ATCC (#1041)
NIH AIDS Research and Reference Reagent
Program, #2857
Dr. Vernon B. Carruthers, University of
Michigan, U.S.A
Dr. Tien-Hsien Chang; Genomics Research
Center, Academia Sinica, China.
Dr. Tien-Hsien Chang; Genomics Research
Center, Academia Sinica, China.

Table B5 Organisms used in study
Organisms used in the study are shown with their corresponding place of
acquisition. For purchased materials, the corresponding lot number is given.
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Parasite/Yeast Expression
Vectors
pYFP-LIC-HX
pSF-TAP-LIC-HX
p414PromDhh1
pRS424-GPD
pCAG-EGFpd2
pSF-TAP-LIC-HX-TgDozi
pYFP-LIC-HX-TgDozi
pRS424-GPD_TgDozi
pS-DD-F-LIC-HX-TgDoZI

Obtained From
Dr. Vernon B. Carruthers, Univ. of Michigan,
U.S.A
Dr. Vernon B. Carruthers, Univ. of Michigan,
U.S.A
Dr. Juana Diez, Universitat Pompeu Fabra, Spain
Dr. Elizabeth Craig, Univ. of Wisconsin, U.S.A
Dr. Markus Meissner, Univ. of Glasgow, Scotland
Constructed for this study

Table B6 Parental plasmids and constructs
The various vectors, both parental constructs for this study, are shown with their
corresponding place of acquisition.
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Oligonucleotide Name
TgDozi.LIC.F (a)
TgDozi.LIC.R (a')
TgDozi_Validate_Fw (b)
TgDozi_Validate_Rv (b')
pEGFP-N1 (c)
cf_Dozi_Fw_pET28
cf_Dozi_Rv_pET28
cf_FW_S_DD_F
cf_RV_S_DD_R
dT-Fish

Sequence
5’-TACTTCCAATCCAATTTAATG
CTACGACGTGAATTG TTGATGG-3’
5’-TCCTCCACTTCCAATTTTAGC
GTAAATTGCTTCGTCAA TCTGG-3’
5’-CTCAGCAGCGCATGCAACAC-3’
5’-TGCGGATGAGACCAAGAACC-3’
5'-GCCGTCCAGCTCGACCAG-3'
5’-GTGCCGCGCGGCAGCCAT
ATGAGCGCAGCCTACTACACC-3’
5’- GTGGTGGTGGTGGTGCTC
GAGTGTGTAAATTGCTTCGTC-3’
5'-CCGCAATTCGAAAAGGGC
GCCGGAGTGCAGGTGGAAACC-3'
5'-GTAATCCTCACCAGAGGC
GCCTTCCGGTTTTAGAAGCTC-3'
5'-/5Biosg/ T(x50)

Table B7 Oligonucleotides used in the study
The complete list of oligonucleotides, and their corresponding sequences, which
were used in this study are shown. All oligonucleotides were purchased from Integrated
DNA Technologies, Inc. (IDT), Coralville, Iowa, U.S.A.
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APPENDIX C

Fw LIC prim er

TgDozi Validate Rv

TgDozi Validate Fw

Rv LIC prim er

First codon of CDS

Last codon of CDS
HoDI Genom ic Sequence

TGGT1 089230 HoDI 583.m00676
6028 bp

Figure C1 Illustration of genomic TgHoDI sequence for creation of expression
plasmids
An illustration of the genomic sequence of TgHoDI (orange) was acquired using
the VNTI software V.10.3.0 (Invitrogen). This was used to assist in the cloning of
subsequent expression plasmids for the endogenous tagging of TgHoDI protein. The
location of oligonucleotide binding sites for the LIC forward and reverse primers are
shown. Also, the binding sites of the validation oligonucleotides used for the
confirmation of transgenic clones is shown.
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univ ersal

SE NS E PRM

HoDI LIC-Genomic Fragment

HoDI-SF TAP-LIC-HX
8541 bp

ANTIS ENSE P RM
Strep tag
FLAG tag
HX cassette

Figure C2 Illustration of TgHoDI-SF transgenic plasmid
An illustration of the expression plasmid for transgenic TgHoDI-SF clones. The
genomic sequence fragment of TgHoDI (orange) was acquired by PCR analysis using the
TgDozi.LIC.F (sense) and TgDozi.LIC.Rv (antisense) oligonucleotides. The location of
streptavidin and FLAG tags are shown. Also, the hypoxanthine-xanthine-guanine
phosphoribosyl transferase (HX) cassette, which is used for transgenic parasite selection,
is shown (green).
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SENSE PRM

HoDI LIC-Genomic Fragment

HoDI-Y FP LIC HX
9135 bp

ANTISENSE PRM
YFP
HX Cassette

Figure C3 Illustration of TgHoDI-YFP transgenic plasmid
An illustration of the expression plasmid for transgenic TgHoDI-YFP clones. The
genomic sequence fragment of TgHoDI (orange) was acquired by PCR analysis using the
TgDozi.LIC.F (sense) and TgDozi.LIC.Rv (antisense) oligonucleotides. The location of
coding sequence for the YFP tag is also shown (orange). The hypoxanthine-xanthineguanine phosphoribosyl transferase (HX) cassette, which is used for transgenic parasite
selection, is shown (green).
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univ ersal

SENSE PRM
HoDI Genomic Fragment

HoDI-S-DD-F-TAP-LIC-HX
8868 bp

ANTISENSE PRM
Linker
Strep tag
ddFKBP
HX cassette

FLAG tag

Figure C4 Illustration of TgHoDI-S-DD-F transgenic plasmid
An illustration of the expression plasmid for transgenic TgHoDI-S-DD-F clones
for knockdown studies. The coding sequence for Strep-ddFKBP-FLAG was acquired by
PCR amplification of pCAG-EGFpd2 vector using the cf_FW_S_DD_F and
cf_FW_S_DD_R oligonucleotides. The TgHoDI-SF-TAP.LIC plasmid was linearized by
SfoI endonuclease which resulted in a single cut in between the streptavidin and FLAG
tags. The amplified ddFKBP CDS was then integrated into the linearized vector via cold
fusion. The hypoxanthine-xanthine-guanine phosphoribosyl transferase (HX) cassette,
which is used for transgenic parasite selection, is shown (green).
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